Log page index: User:ProteinBoxBot/PBB_Log_Index
Protein Status Quick Log - Date: 08:20, 19 November 2007 (UTC)
[edit]Proteins without matches (12)
[edit]Proteins with a High Potential Match (6)
[edit]Redirected Proteins (7)
[edit]Manual Inspection (Page not found) (18)
[edit]
Protein Status Grid - Date: 08:20, 19 November 2007 (UTC)
[edit]Vebose Log - Date: 08:20, 19 November 2007 (UTC)
[edit]- INFO: Beginning work on ABL2... {November 18, 2007 11:58:19 PM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 18, 2007 11:58:46 PM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image = PBB_Protein_ABL2_image.jpg
| image_source = [[Protein_Data_Bank|PDB]] rendering based on 1ab2.
| PDB = {{PDB2|1ab2}}, {{PDB2|1abo}}, {{PDB2|1abq}}, {{PDB2|1bbz}}, {{PDB2|1fpu}}, {{PDB2|1iep}}, {{PDB2|1ju5}}, {{PDB2|1m52}}, {{PDB2|1opj}}, {{PDB2|2e2b}}, {{PDB2|2f4j}}, {{PDB2|2g1t}}, {{PDB2|2g2f}}, {{PDB2|2g2h}}, {{PDB2|2g2i}}, {{PDB2|2gqg}}, {{PDB2|2hiw}}, {{PDB2|2hyy}}, {{PDB2|2hz0}}, {{PDB2|2hz4}}, {{PDB2|2hzi}}, {{PDB2|2hzn}}
| Name = V-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)
| HGNCid = 77
| Symbol = ABL2
| AltSymbols =; ABLL; ARG
| OMIM = 164690
| ECnumber =
| Homologene = 5278
| MGIid = 87860
| GeneAtlas_image1 = PBB_GE_ABL2_206411_s_at_tn.png
| Function = {{GNF_GO|id=GO:0000166 |text = nucleotide binding}} {{GNF_GO|id=GO:0000287 |text = magnesium ion binding}} {{GNF_GO|id=GO:0004713 |text = protein-tyrosine kinase activity}} {{GNF_GO|id=GO:0005515 |text = protein binding}} {{GNF_GO|id=GO:0005524 |text = ATP binding}} {{GNF_GO|id=GO:0016740 |text = transferase activity}} {{GNF_GO|id=GO:0030145 |text = manganese ion binding}} {{GNF_GO|id=GO:0035014 |text = phosphoinositide 3-kinase regulator activity}}
| Component = {{GNF_GO|id=GO:0005737 |text = cytoplasm}} {{GNF_GO|id=GO:0005942 |text = phosphoinositide 3-kinase complex}} {{GNF_GO|id=GO:0015629 |text = actin cytoskeleton}}
| Process = {{GNF_GO|id=GO:0007155 |text = cell adhesion}} {{GNF_GO|id=GO:0007242 |text = intracellular signaling cascade}} {{GNF_GO|id=GO:0018108 |text = peptidyl-tyrosine phosphorylation}} {{GNF_GO|id=GO:0051017 |text = actin filament bundle formation}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 27
| Hs_Ensembl = ENSG00000143322
| Hs_RefseqProtein = NP_005149
| Hs_RefseqmRNA = NM_005158
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 1
| Hs_GenLoc_start = 177339806
| Hs_GenLoc_end = 177465359
| Hs_Uniprot = P42684
| Mm_EntrezGene = 11352
| Mm_Ensembl = ENSMUSG00000026596
| Mm_RefseqmRNA = NM_009595
| Mm_RefseqProtein = NP_033725
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 1
| Mm_GenLoc_start = 158395726
| Mm_GenLoc_end = 158479393
| Mm_Uniprot = Q61055
}}
}}
'''V-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)''', also known as '''ABL2''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: ABL2 v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=27| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = ABL2 is a cytoplasmic tyrosine kinase which is closely related to but distinct from ABL1. The similarity of the proteins includes the tyrosine kinase domains and extends amino-terminal to include the SH2 and SH3 domains. ABL2 is expressed in both normal and tumor cells. The ABL2 gene product is expressed as two variants bearing different amino termini, both approximately 12-kb in length.<ref name="entrez">{{cite web | title = Entrez Gene: ABL2 v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=27| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Pendergast AM |title=The Abl family kinases: mechanisms of regulation and signaling. |journal=Adv. Cancer Res. |volume=85 |issue= |pages= 51-100 |year= 2003 |pmid= 12374288 |doi= }}
*{{cite journal | author=Muller AJ, Pendergast AM, Havlik MH, ''et al.'' |title=A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction. |journal=Mol. Cell. Biol. |volume=12 |issue= 11 |pages= 5087-93 |year= 1992 |pmid= 1383690 |doi= }}
*{{cite journal | author=Kruh GD, Perego R, Miki T, Aaronson SA |title=The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=87 |issue= 15 |pages= 5802-6 |year= 1990 |pmid= 2198571 |doi= }}
*{{cite journal | author=Kruh GD, King CR, Kraus MH, ''et al.'' |title=A novel human gene closely related to the abl proto-oncogene. |journal=Science |volume=234 |issue= 4783 |pages= 1545-8 |year= 1987 |pmid= 3787260 |doi= }}
*{{cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171-4 |year= 1994 |pmid= 8125298 |doi= }}
*{{cite journal | author=Wang B, Kruh GD |title=Subcellular localization of the Arg protein tyrosine kinase. |journal=Oncogene |volume=13 |issue= 1 |pages= 193-7 |year= 1996 |pmid= 8700546 |doi= }}
*{{cite journal | author=Wang B, Mysliwiec T, Feller SM, ''et al.'' |title=Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk. |journal=Oncogene |volume=13 |issue= 7 |pages= 1379-85 |year= 1996 |pmid= 8875975 |doi= }}
*{{cite journal | author=Wang B, Golemis EA, Kruh GD |title=ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks. |journal=J. Biol. Chem. |volume=272 |issue= 28 |pages= 17542-50 |year= 1997 |pmid= 9211900 |doi= }}
*{{cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149-56 |year= 1997 |pmid= 9373149 |doi= }}
*{{cite journal | author=Koval AP, Blakesley VA, Roberts CT, ''et al.'' |title=Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor. |journal=Biochem. J. |volume=330 ( Pt 2) |issue= |pages= 923-32 |year= 1998 |pmid= 9480911 |doi= }}
*{{cite journal | author=Hashimoto Y, Katayama H, Kiyokawa E, ''et al.'' |title=Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor. |journal=J. Biol. Chem. |volume=273 |issue= 27 |pages= 17186-91 |year= 1998 |pmid= 9642287 |doi= }}
*{{cite journal | author=Danial NN, Losman JA, Lu T, ''et al.'' |title=Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation. |journal=Mol. Cell. Biol. |volume=18 |issue= 11 |pages= 6795-804 |year= 1998 |pmid= 9774693 |doi= }}
*{{cite journal | author=Cao C, Ren X, Kharbanda S, ''et al.'' |title=The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress. |journal=J. Biol. Chem. |volume=276 |issue= 15 |pages= 11465-8 |year= 2001 |pmid= 11278261 |doi= 10.1074/jbc.C100050200 }}
*{{cite journal | author=Yu HH, Zisch AH, Dodelet VC, Pasquale EB |title=Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor. |journal=Oncogene |volume=20 |issue= 30 |pages= 3995-4006 |year= 2001 |pmid= 11494128 |doi= 10.1038/sj.onc.1204524 }}
*{{cite journal | author=Endo A, Nagashima K, Kurose H, ''et al.'' |title=Sphingosine 1-phosphate induces membrane ruffling and increases motility of human umbilical vein endothelial cells via vascular endothelial growth factor receptor and CrkII. |journal=J. Biol. Chem. |volume=277 |issue= 26 |pages= 23747-54 |year= 2002 |pmid= 11956190 |doi= 10.1074/jbc.M111794200 }}
*{{cite journal | author=Abassi YA, Vuori K |title=Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of Rac signaling. |journal=EMBO J. |volume=21 |issue= 17 |pages= 4571-82 |year= 2002 |pmid= 12198159 |doi= }}
*{{cite journal | author=Bianchi C, Muradore I, Corizzato M, ''et al.'' |title=The expression of the non-receptor tyrosine kinases Arg and c-abl is differently modulated in B lymphoid cells at different stages of differentiation. |journal=FEBS Lett. |volume=527 |issue= 1-3 |pages= 216-222 |year= 2002 |pmid= 12220663 |doi= }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal | author=Salomon AR, Ficarro SB, Brill LM, ''et al.'' |title=Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=100 |issue= 2 |pages= 443-8 |year= 2003 |pmid= 12522270 |doi= 10.1073/pnas.2436191100 }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on ANXA6... {November 18, 2007 11:58:46 PM PST}
- SEARCH REDIRECT: Control Box Found: ANXA6 {November 18, 2007 11:59:12 PM PST}
- UPDATE PROTEIN BOX: Updating Protein Box, No errors. {November 18, 2007 11:59:13 PM PST}
- UPDATE SUMMARY: Updating Summary, No Errors. {November 18, 2007 11:59:13 PM PST}
- UPDATE CITATIONS: Updating Citations, No Errors. {November 18, 2007 11:59:13 PM PST}
- UPDATED: Updated protein page: ANXA6 {November 18, 2007 11:59:19 PM PST}
- INFO: Beginning work on ARAF... {November 18, 2007 11:59:19 PM PST}
- SEARCH REDIRECT: Control Box Found: ARAF {November 18, 2007 11:59:54 PM PST}
- UPDATE PROTEIN BOX: Updating Protein Box, No errors. {November 18, 2007 11:59:55 PM PST}
- UPDATE SUMMARY: Updating Summary, No Errors. {November 18, 2007 11:59:55 PM PST}
- UPDATE CITATIONS: Updating Citations, No Errors. {November 18, 2007 11:59:55 PM PST}
- UPDATED: Updated protein page: ARAF {November 19, 2007 12:00:03 AM PST}
- INFO: Beginning work on BLNK... {November 19, 2007 12:12:02 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:12:35 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = B-cell linker
| HGNCid = 14211
| Symbol = BLNK
| AltSymbols =; BASH; BLNK-s; Ly57; MGC111051; SLP-65; SLP65
| OMIM = 604515
| ECnumber =
| Homologene = 32038
| MGIid = 96878
| GeneAtlas_image1 = PBB_GE_BLNK_207655_s_at_tn.png
| Function = {{GNF_GO|id=GO:0005068 |text = transmembrane receptor protein tyrosine kinase adaptor protein activity}} {{GNF_GO|id=GO:0005070 |text = SH3/SH2 adaptor activity}} {{GNF_GO|id=GO:0005515 |text = protein binding}}
| Component = {{GNF_GO|id=GO:0005622 |text = intracellular}} {{GNF_GO|id=GO:0005737 |text = cytoplasm}}
| Process = {{GNF_GO|id=GO:0006954 |text = inflammatory response}} {{GNF_GO|id=GO:0006959 |text = humoral immune response}} {{GNF_GO|id=GO:0007242 |text = intracellular signaling cascade}} {{GNF_GO|id=GO:0007516 |text = hemocyte development}} {{GNF_GO|id=GO:0030183 |text = B cell differentiation}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 29760
| Hs_Ensembl = ENSG00000095585
| Hs_RefseqProtein = NP_037446
| Hs_RefseqmRNA = NM_013314
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 10
| Hs_GenLoc_start = 97941453
| Hs_GenLoc_end = 98021316
| Hs_Uniprot = Q8WV28
| Mm_EntrezGene = 17060
| Mm_Ensembl = ENSMUSG00000061132
| Mm_RefseqmRNA = NM_008528
| Mm_RefseqProtein = NP_032554
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 19
| Mm_GenLoc_start = 40982484
| Mm_GenLoc_end = 41025964
| Mm_Uniprot = Q9QUN3
}}
}}
'''B-cell linker''', also known as '''BLNK''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: BLNK B-cell linker| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=29760| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = Linker or adaptor proteins provide mechanisms by which receptors can amplify and regulate downstream effector proteins. The B-cell linker protein is essential for normal B-cell development.[supplied by OMIM]<ref name="entrez">{{cite web | title = Entrez Gene: BLNK B-cell linker| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=29760| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171-4 |year= 1994 |pmid= 8125298 |doi= }}
*{{cite journal | author=Fu C, Chan AC |title=Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cgamma, Grb2, and Vav after B cell antigen receptor activation. |journal=J. Biol. Chem. |volume=272 |issue= 43 |pages= 27362-8 |year= 1997 |pmid= 9341187 |doi= }}
*{{cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149-56 |year= 1997 |pmid= 9373149 |doi= }}
*{{cite journal | author=Fu C, Turck CW, Kurosaki T, Chan AC |title=BLNK: a central linker protein in B cell activation. |journal=Immunity |volume=9 |issue= 1 |pages= 93-103 |year= 1998 |pmid= 9697839 |doi= }}
*{{cite journal | author=Wienands J, Schweikert J, Wollscheid B, ''et al.'' |title=SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. |journal=J. Exp. Med. |volume=188 |issue= 4 |pages= 791-5 |year= 1998 |pmid= 9705962 |doi= }}
*{{cite journal | author=Hashimoto S, Iwamatsu A, Ishiai M, ''et al.'' |title=Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. |journal=Blood |volume=94 |issue= 7 |pages= 2357-64 |year= 1999 |pmid= 10498607 |doi= }}
*{{cite journal | author=Su YW, Zhang Y, Schweikert J, ''et al.'' |title=Interaction of SLP adaptors with the SH2 domain of Tec family kinases. |journal=Eur. J. Immunol. |volume=29 |issue= 11 |pages= 3702-11 |year= 1999 |pmid= 10556826 |doi= }}
*{{cite journal | author=Minegishi Y, Rohrer J, Coustan-Smith E, ''et al.'' |title=An essential role for BLNK in human B cell development. |journal=Science |volume=286 |issue= 5446 |pages= 1954-7 |year= 1999 |pmid= 10583958 |doi= }}
*{{cite journal | author=Fusaki N, Tomita S, Wu Y, ''et al.'' |title=BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking. |journal=Eur. J. Immunol. |volume=30 |issue= 5 |pages= 1326-30 |year= 2000 |pmid= 10820378 |doi= }}
*{{cite journal | author=Mizuno K, Tagawa Y, Mitomo K, ''et al.'' |title=Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells. |journal=J. Immunol. |volume=165 |issue= 3 |pages= 1344-51 |year= 2000 |pmid= 10903736 |doi= }}
*{{cite journal | author=Guo B, Kato RM, Garcia-Lloret M, ''et al.'' |title=Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. |journal=Immunity |volume=13 |issue= 2 |pages= 243-53 |year= 2000 |pmid= 10981967 |doi= }}
*{{cite journal | author=Watanabe S, Take H, Takeda K, ''et al.'' |title=Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes. |journal=Biochem. Biophys. Res. Commun. |volume=278 |issue= 1 |pages= 167-74 |year= 2001 |pmid= 11071869 |doi= 10.1006/bbrc.2000.3760 }}
*{{cite journal | author=Tan JE, Wong SC, Gan SK, ''et al.'' |title=The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes. |journal=J. Biol. Chem. |volume=276 |issue= 23 |pages= 20055-63 |year= 2001 |pmid= 11274146 |doi= 10.1074/jbc.M010800200 }}
*{{cite journal | author=Adachi T, Wienands J, Wakabayashi C, ''et al.'' |title=SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates. |journal=J. Biol. Chem. |volume=276 |issue= 28 |pages= 26648-55 |year= 2001 |pmid= 11356834 |doi= 10.1074/jbc.M100997200 }}
*{{cite journal | author=Engels N, Wollscheid B, Wienands J |title=Association of SLP-65/BLNK with the B cell antigen receptor through a non-ITAM tyrosine of Ig-alpha. |journal=Eur. J. Immunol. |volume=31 |issue= 7 |pages= 2126-34 |year= 2001 |pmid= 11449366 |doi= }}
*{{cite journal | author=Sauer K, Liou J, Singh SB, ''et al.'' |title=Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes. |journal=J. Biol. Chem. |volume=276 |issue= 48 |pages= 45207-16 |year= 2002 |pmid= 11487585 |doi= 10.1074/jbc.M106811200 }}
*{{cite journal | author=Engels N, Merchant M, Pappu R, ''et al.'' |title=Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. |journal=J. Exp. Med. |volume=194 |issue= 3 |pages= 255-64 |year= 2001 |pmid= 11489945 |doi= }}
*{{cite journal | author=Tsuji S, Okamoto M, Yamada K, ''et al.'' |title=B cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1. |journal=J. Exp. Med. |volume=194 |issue= 4 |pages= 529-39 |year= 2001 |pmid= 11514608 |doi= }}
*{{cite journal | author=Kabak S, Skaggs BJ, Gold MR, ''et al.'' |title=The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways. |journal=Mol. Cell. Biol. |volume=22 |issue= 8 |pages= 2524-35 |year= 2002 |pmid= 11909947 |doi= }}
*{{cite journal | author=Yasuda T, Tezuka T, Maeda A, ''et al.'' |title=Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells. |journal=J. Exp. Med. |volume=196 |issue= 1 |pages= 51-63 |year= 2002 |pmid= 12093870 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on CEACAM6... {November 19, 2007 12:11:10 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:11:38 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
| HGNCid = 1818
| Symbol = CEACAM6
| AltSymbols =; NCA; CD66c; CEAL
| OMIM = 163980
| ECnumber =
| Homologene =
| MGIid =
| GeneAtlas_image1 = PBB_GE_CEACAM6_203757_s_at_tn.png
| GeneAtlas_image2 = PBB_GE_CEACAM6_211657_at_tn.png
| Function = {{GNF_GO|id=GO:0048503 |text = GPI anchor binding}}
| Component = {{GNF_GO|id=GO:0005887 |text = integral to plasma membrane}} {{GNF_GO|id=GO:0016020 |text = membrane}}
| Process = {{GNF_GO|id=GO:0007165 |text = signal transduction}} {{GNF_GO|id=GO:0007267 |text = cell-cell signaling}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 4680
| Hs_Ensembl = ENSG00000086548
| Hs_RefseqProtein = NP_002474
| Hs_RefseqmRNA = NM_002483
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 19
| Hs_GenLoc_start = 46951337
| Hs_GenLoc_end = 46967953
| Hs_Uniprot = P40199
| Mm_EntrezGene =
| Mm_Ensembl =
| Mm_RefseqmRNA =
| Mm_RefseqProtein =
| Mm_GenLoc_db =
| Mm_GenLoc_chr =
| Mm_GenLoc_start =
| Mm_GenLoc_end =
| Mm_Uniprot =
}}
}}
'''Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)''', also known as '''CEACAM6''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: CEACAM6 carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4680| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text =
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Oikawa S, Inuzuka C, Kuroki M, ''et al.'' |title=A specific heterotypic cell adhesion activity between members of carcinoembryonic antigen family, W272 and NCA, is mediated by N-domains. |journal=J. Biol. Chem. |volume=266 |issue= 13 |pages= 7995-8001 |year= 1991 |pmid= 2022629 |doi= }}
*{{cite journal | author=Haus O, Noworolska A, Laskowski M, ''et al.'' |title=Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia. |journal=Exp. Mol. Pathol. |volume=52 |issue= 2 |pages= 235-42 |year= 1990 |pmid= 2332039 |doi= }}
*{{cite journal | author=Hefta SA, Paxton RJ, Shively JE |title=Sequence and glycosylation site identity of two distinct glycoforms of nonspecific cross-reacting antigen as demonstrated by sequence analysis and fast atom bombardment mass spectrometry. |journal=J. Biol. Chem. |volume=265 |issue= 15 |pages= 8618-26 |year= 1990 |pmid= 2341397 |doi= }}
*{{cite journal | author=Inazawa J, Abe T, Inoue K, ''et al.'' |title=Regional assignment of nonspecific cross-reacting antigen (NCA) of the CEA gene family to chromosome 19 at band q13.2. |journal=Cytogenet. Cell Genet. |volume=52 |issue= 1-2 |pages= 28-31 |year= 1990 |pmid= 2612212 |doi= }}
*{{cite journal | author=Neumaier M, Zimmermann W, Shively L, ''et al.'' |title=Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen. |journal=J. Biol. Chem. |volume=263 |issue= 7 |pages= 3202-7 |year= 1988 |pmid= 2830274 |doi= }}
*{{cite journal | author=Kuroki M, Kuroki M, Moore GE, ''et al.'' |title=The molecular heterogeneity of nonspecific cross-reacting antigen synthesized by tumor cells and granulocytes. |journal=Jpn. J. Cancer Res. |volume=79 |issue= 1 |pages= 82-90 |year= 1988 |pmid= 3128509 |doi= }}
*{{cite journal | author=Barnett T, Goebel SJ, Nothdurft MA, Elting JJ |title=Carcinoembryonic antigen family: characterization of cDNAs coding for NCA and CEA and suggestion of nonrandom sequence variation in their conserved loop-domains. |journal=Genomics |volume=3 |issue= 1 |pages= 59-66 |year= 1989 |pmid= 3220478 |doi= }}
*{{cite journal | author=Tawaragi Y, Oikawa S, Matsuoka Y, ''et al.'' |title=Primary structure of nonspecific crossreacting antigen (NCA), a member of carcinoembryonic antigen (CEA) gene family, deduced from cDNA sequence. |journal=Biochem. Biophys. Res. Commun. |volume=150 |issue= 1 |pages= 89-96 |year= 1988 |pmid= 3337731 |doi= }}
*{{cite journal | author=Noworolska A, Harłozińska-Szmyrka A, Richter R |title=Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series. |journal=Cancer Detect. Prev. |volume=9 |issue= 3-4 |pages= 365-71 |year= 1986 |pmid= 3527416 |doi= }}
*{{cite journal | author=Oikawa S, Kosaki G, Nakazato H |title=Molecular cloning of a gene for a member of carcinoembryonic antigen (CEA) gene family; signal peptide and N-terminal domain sequences of nonspecific crossreacting antigen (NCA). |journal=Biochem. Biophys. Res. Commun. |volume=146 |issue= 2 |pages= 464-9 |year= 1987 |pmid= 3619891 |doi= }}
*{{cite journal | author=Watt SM, Fawcett J, Murdoch SJ, ''et al.'' |title=CD66 identifies the biliary glycoprotein (BGP) adhesion molecule: cloning, expression, and adhesion functions of the BGPc splice variant. |journal=Blood |volume=84 |issue= 1 |pages= 200-10 |year= 1994 |pmid= 8018919 |doi= }}
*{{cite journal | author=Honda Y, Egawa K, Kuroki M, Ono T |title=Hair cycle-dependent expression of a nonspecific cross reacting antigen (NCA)-50/90-like molecule on follicular keratinocytes. |journal=Arch. Dermatol. Res. |volume=289 |issue= 8 |pages= 457-65 |year= 1997 |pmid= 9266023 |doi= }}
*{{cite journal | author=Schölzel S, Zimmermann W, Schwarzkopf G, ''et al.'' |title=Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. |journal=Am. J. Pathol. |volume=156 |issue= 2 |pages= 595-605 |year= 2000 |pmid= 10666389 |doi= }}
*{{cite journal | author=Oikawa S, Sugiyama M, Kuroki M, ''et al.'' |title=Extracellular N-domain alone can mediate specific heterophilic adhesion between members of the carcinoembryonic antigen family, CEACAM6 and CEACAM8. |journal=Biochem. Biophys. Res. Commun. |volume=278 |issue= 3 |pages= 564-8 |year= 2001 |pmid= 11095950 |doi= 10.1006/bbrc.2000.3858 }}
*{{cite journal | author=Ilantzis C, DeMarte L, Screaton RA, Stanners CP |title=Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. |journal=Neoplasia |volume=4 |issue= 2 |pages= 151-63 |year= 2002 |pmid= 11896570 |doi= 10.1038/sj/neo/7900201 }}
*{{cite journal | author=Singer BB, Scheffrahn I, Heymann R, ''et al.'' |title=Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes. |journal=J. Immunol. |volume=168 |issue= 10 |pages= 5139-46 |year= 2002 |pmid= 11994468 |doi= }}
*{{cite journal | author=Skubitz KM, Campbell KD, Skubitz AP |title=Synthetic peptides from the N-domains of CEACAMs activate neutrophils. |journal=J. Pept. Res. |volume=58 |issue= 6 |pages= 515-26 |year= 2002 |pmid= 12005421 |doi= }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal | author=Taheri M, Saragovi HU, Stanners CP |title=The adhesion and differentiation-inhibitory activities of the immunoglobulin superfamily member, carcinoembryonic antigen, can be independently blocked. |journal=J. Biol. Chem. |volume=278 |issue= 17 |pages= 14632-9 |year= 2003 |pmid= 12571231 |doi= 10.1074/jbc.M212500200 }}
*{{cite journal | author=Duxbury MS, Ito H, Zinner MJ, ''et al.'' |title=CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. |journal=Oncogene |volume=23 |issue= 2 |pages= 465-73 |year= 2004 |pmid= 14724575 |doi= 10.1038/sj.onc.1207036 }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on DARC... {November 19, 2007 12:01:20 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:01:54 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Duffy blood group, chemokine receptor
| HGNCid = 4035
| Symbol = DARC
| AltSymbols =; CCBP1; CD234; Dfy; FY; GPD
| OMIM = 110700
| ECnumber =
| Homologene = 48067
| MGIid = 1097689
| Function = {{GNF_GO|id=GO:0001584 |text = rhodopsin-like receptor activity}} {{GNF_GO|id=GO:0004950 |text = chemokine receptor activity}}
| Component = {{GNF_GO|id=GO:0005886 |text = plasma membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}}
| Process = {{GNF_GO|id=GO:0006952 |text = defense response}} {{GNF_GO|id=GO:0007165 |text = signal transduction}} {{GNF_GO|id=GO:0007186 |text = G-protein coupled receptor protein signaling pathway}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 2532
| Hs_Ensembl =
| Hs_RefseqProtein = NP_002027
| Hs_RefseqmRNA = NM_002036
| Hs_GenLoc_db =
| Hs_GenLoc_chr =
| Hs_GenLoc_start =
| Hs_GenLoc_end =
| Hs_Uniprot =
| Mm_EntrezGene = 13349
| Mm_Ensembl = ENSMUSG00000037872
| Mm_RefseqmRNA = NM_010045
| Mm_RefseqProtein = NP_034175
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 1
| Mm_GenLoc_start = 175168621
| Mm_GenLoc_end = 175170348
| Mm_Uniprot = Q53ZP8
}}
}}
'''Duffy blood group, chemokine receptor''', also known as '''DARC''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: DARC Duffy blood group, chemokine receptor| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2532| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text =
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Pogo AO, Chaudhuri A |title=Duffy and receptors for P. vivax and chemotactic peptides. |journal=Transfusion clinique et biologique : journal de la Société française de transfusion sanguine |volume=2 |issue= 4 |pages= 269-76 |year= 1996 |pmid= 8542025 |doi= }}
*{{cite journal | author=Pruenster M, Rot A |title=Throwing light on DARC. |journal=Biochem. Soc. Trans. |volume=34 |issue= Pt 6 |pages= 1005-8 |year= 2007 |pmid= 17073738 |doi= 10.1042/BST0341005 }}
*{{cite journal | author=Raeymaekers P, Van Broeckhoven C, Backhovens H, ''et al.'' |title=The Duffy blood group is linked to the alpha-spectrin locus in a large pedigree with autosomal dominant inheritance of Charcot-Marie-Tooth disease type 1. |journal=Hum. Genet. |volume=78 |issue= 1 |pages= 76-8 |year= 1988 |pmid= 2892777 |doi= }}
*{{cite journal | author=Lu ZH, Wang ZX, Horuk R, ''et al.'' |title=The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. |journal=J. Biol. Chem. |volume=270 |issue= 44 |pages= 26239-45 |year= 1995 |pmid= 7592830 |doi= }}
*{{cite journal | author=Tournamille C, Colin Y, Cartron JP, Le Van Kim C |title=Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. |journal=Nat. Genet. |volume=10 |issue= 2 |pages= 224-8 |year= 1995 |pmid= 7663520 |doi= 10.1038/ng0695-224 }}
*{{cite journal | author=Horuk R, Chitnis CE, Darbonne WC, ''et al.'' |title=A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. |journal=Science |volume=261 |issue= 5125 |pages= 1182-4 |year= 1993 |pmid= 7689250 |doi= }}
*{{cite journal | author=Tournamille C, Le Van Kim C, Gane P, ''et al.'' |title=Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. |journal=Hum. Genet. |volume=95 |issue= 4 |pages= 407-10 |year= 1995 |pmid= 7705836 |doi= }}
*{{cite journal | author=Iwamoto S, Omi T, Kajii E, Ikemoto S |title=Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. |journal=Blood |volume=85 |issue= 3 |pages= 622-6 |year= 1995 |pmid= 7833467 |doi= }}
*{{cite journal | author=Chaudhuri A, Polyakova J, Zbrzezna V, ''et al.'' |title=Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=90 |issue= 22 |pages= 10793-7 |year= 1993 |pmid= 8248172 |doi= }}
*{{cite journal | author=Horuk R, Martin AW, Wang Z, ''et al.'' |title=Expression of chemokine receptors by subsets of neurons in the central nervous system. |journal=J. Immunol. |volume=158 |issue= 6 |pages= 2882-90 |year= 1997 |pmid= 9058825 |doi= }}
*{{cite journal | author=Tournamille C, Le Van Kim C, Gane P, ''et al.'' |title=Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. |journal=J. Biol. Chem. |volume=272 |issue= 26 |pages= 16274-80 |year= 1997 |pmid= 9195930 |doi= }}
*{{cite journal | author=Tournamille C, Le Van Kim C, Gane P, ''et al.'' |title=Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. |journal=Blood |volume=92 |issue= 6 |pages= 2147-56 |year= 1998 |pmid= 9731074 |doi= }}
*{{cite journal | author=Parasol N, Reid M, Rios M, ''et al.'' |title=A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. |journal=Blood |volume=92 |issue= 7 |pages= 2237-43 |year= 1998 |pmid= 9746760 |doi= }}
*{{cite journal | author=Olsson ML, Smythe JS, Hansson C, ''et al.'' |title=The Fy(x) phenotype is associated with a missense mutation in the Fy(b) allele predicting Arg89Cys in the Duffy glycoprotein. |journal=Br. J. Haematol. |volume=103 |issue= 4 |pages= 1184-91 |year= 1999 |pmid= 9886340 |doi= }}
*{{cite journal | author=Lachgar A, Jaureguiberry G, Le Buenac H, ''et al.'' |title=Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC). |journal=Biomed. Pharmacother. |volume=52 |issue= 10 |pages= 436-9 |year= 1999 |pmid= 9921412 |doi= }}
*{{cite journal | author=Zimmerman PA, Woolley I, Masinde GL, ''et al.'' |title=Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=96 |issue= 24 |pages= 13973-7 |year= 2000 |pmid= 10570183 |doi= }}
*{{cite journal | author=Woolley IJ, Kalayjian R, Valdez H, ''et al.'' |title=HIV nephropathy and the Duffy antigen/receptor for Chemokines in African Americans. |journal=J. Nephrol. |volume=14 |issue= 5 |pages= 384-7 |year= 2002 |pmid= 11730271 |doi= }}
*{{cite journal | author=Hamblin MT, Thompson EE, Di Rienzo A |title=Complex signatures of natural selection at the Duffy blood group locus. |journal=Am. J. Hum. Genet. |volume=70 |issue= 2 |pages= 369-83 |year= 2002 |pmid= 11753822 |doi= }}
*{{cite journal | author=Patterson AM, Siddall H, Chamberlain G, ''et al.'' |title=Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium. |journal=J. Pathol. |volume=197 |issue= 1 |pages= 108-16 |year= 2002 |pmid= 12081195 |doi= 10.1002/path.1100 }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on FOLR1... {November 19, 2007 12:00:03 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:00:41 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Folate receptor 1 (adult)
| HGNCid = 3791
| Symbol = FOLR1
| AltSymbols =; FBP; FOLR; FR-alpha; MOv18
| OMIM = 136430
| ECnumber =
| Homologene = 7322
| MGIid = 95568
| GeneAtlas_image1 = PBB_GE_FOLR1_204437_s_at_tn.png
| Function = {{GNF_GO|id=GO:0004872 |text = receptor activity}} {{GNF_GO|id=GO:0005542 |text = folic acid binding}} {{GNF_GO|id=GO:0048503 |text = GPI anchor binding}}
| Component = {{GNF_GO|id=GO:0005624 |text = membrane fraction}} {{GNF_GO|id=GO:0005887 |text = integral to plasma membrane}} {{GNF_GO|id=GO:0016020 |text = membrane}}
| Process = {{GNF_GO|id=GO:0006898 |text = receptor-mediated endocytosis}} {{GNF_GO|id=GO:0015884 |text = folic acid transport}} {{GNF_GO|id=GO:0046655 |text = folic acid metabolic process}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 2348
| Hs_Ensembl = ENSG00000110195
| Hs_RefseqProtein = NP_000793
| Hs_RefseqmRNA = NM_000802
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 11
| Hs_GenLoc_start = 71578250
| Hs_GenLoc_end = 71584992
| Hs_Uniprot = P15328
| Mm_EntrezGene = 14275
| Mm_Ensembl = ENSMUSG00000001827
| Mm_RefseqmRNA = NM_008034
| Mm_RefseqProtein = NP_032060
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 7
| Mm_GenLoc_start = 101732171
| Mm_GenLoc_end = 101744602
| Mm_Uniprot = A1A4B2
}}
}}
'''Folate receptor 1 (adult)''', also known as '''FOLR1''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: FOLR1 folate receptor 1 (adult)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2348| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = The protein encoded by this gene is a member of the folate receptor (FOLR) family. Members of this gene family have a high affinity for folic acid and for several reduced folic acid derivatives, and mediate delivery of 5-methyltetrahydrofolate to the interior of cells. This gene is composed of 7 exons; exons 1 through 4 encode the 5' UTR and exons 4 through 7 encode the open reading frame. Due to the presence of 2 promoters, multiple transcription start sites, and alternative splicing of exons, several transcript variants are derived from this gene. These variants differ in the lengths of 5' and 3' UTR, but they encode an identical amino acid sequence.<ref name="entrez">{{cite web | title = Entrez Gene: FOLR1 folate receptor 1 (adult)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2348| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Henderson GB |title=Folate-binding proteins. |journal=Annu. Rev. Nutr. |volume=10 |issue= |pages= 319-35 |year= 1990 |pmid= 2166548 |doi= 10.1146/annurev.nu.10.070190.001535 }}
*{{cite journal | author=Kelemen LE |title=The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? |journal=Int. J. Cancer |volume=119 |issue= 2 |pages= 243-50 |year= 2006 |pmid= 16453285 |doi= 10.1002/ijc.21712 }}
*{{cite journal | author=Ragoussis J, Senger G, Trowsdale J, Campbell IG |title=Genomic organization of the human folate receptor genes on chromosome 11q13. |journal=Genomics |volume=14 |issue= 2 |pages= 423-30 |year= 1992 |pmid= 1330883 |doi= }}
*{{cite journal | author=Sadasivan E, Cedeno M, Rothenberg SP |title=Genomic organization of the gene and a related pseudogene for a human folate binding protein. |journal=Biochim. Biophys. Acta |volume=1131 |issue= 1 |pages= 91-4 |year= 1992 |pmid= 1581364 |doi= }}
*{{cite journal | author=Campbell IG, Jones TA, Foulkes WD, Trowsdale J |title=Folate-binding protein is a marker for ovarian cancer. |journal=Cancer Res. |volume=51 |issue= 19 |pages= 5329-38 |year= 1991 |pmid= 1717147 |doi= }}
*{{cite journal | author=Coney LR, Tomassetti A, Carayannopoulos L, ''et al.'' |title=Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. |journal=Cancer Res. |volume=51 |issue= 22 |pages= 6125-32 |year= 1991 |pmid= 1840502 |doi= }}
*{{cite journal | author=Lacey SW, Sanders JM, Rothberg KG, ''et al.'' |title=Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. |journal=J. Clin. Invest. |volume=84 |issue= 2 |pages= 715-20 |year= 1989 |pmid= 2527252 |doi= }}
*{{cite journal | author=Sadasivan E, Rothenberg SP |title=The complete amino acid sequence of a human folate binding protein from KB cells determined from the cDNA. |journal=J. Biol. Chem. |volume=264 |issue= 10 |pages= 5806-11 |year= 1989 |pmid= 2538429 |doi= }}
*{{cite journal | author=Elwood PC |title=Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture (KB) cells. |journal=J. Biol. Chem. |volume=264 |issue= 25 |pages= 14893-901 |year= 1989 |pmid= 2768245 |doi= }}
*{{cite journal | author=Sadasivan E, Rothenberg SP |title=Molecular cloning of the complementary DNA for a human folate binding protein. |journal=Proc. Soc. Exp. Biol. Med. |volume=189 |issue= 2 |pages= 240-4 |year= 1989 |pmid= 3194438 |doi= }}
*{{cite journal | author=Luhrs CA, Pitiranggon P, da Costa M, ''et al.'' |title=Purified membrane and soluble folate binding proteins from cultured KB cells have similar amino acid compositions and molecular weights but differ in fatty acid acylation. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=84 |issue= 18 |pages= 6546-9 |year= 1987 |pmid= 3476960 |doi= }}
*{{cite journal | author=Yan W, Ratnam M |title=Preferred sites of glycosylphosphatidylinositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal. |journal=Biochemistry |volume=34 |issue= 44 |pages= 14594-600 |year= 1995 |pmid= 7578066 |doi= }}
*{{cite journal | author=Saikawa Y, Price K, Hance KW, ''et al.'' |title=Structural and functional analysis of the human KB cell folate receptor gene P4 promoter: cooperation of three clustered Sp1-binding sites with initiator region for basal promoter activity. |journal=Biochemistry |volume=34 |issue= 31 |pages= 9951-61 |year= 1995 |pmid= 7632694 |doi= }}
*{{cite journal | author=Prasad PD, Ramamoorthy S, Moe AJ, ''et al.'' |title=Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. |journal=Biochim. Biophys. Acta |volume=1223 |issue= 1 |pages= 71-5 |year= 1994 |pmid= 8061055 |doi= }}
*{{cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171-4 |year= 1994 |pmid= 8125298 |doi= }}
*{{cite journal | author=Elwood PC, Nachmanoff K, Saikawa Y, ''et al.'' |title=The divergent 5' termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promoters and alternative splicing: characterization of the alpha hFR gene structure. |journal=Biochemistry |volume=36 |issue= 6 |pages= 1467-78 |year= 1997 |pmid= 9063895 |doi= 10.1021/bi962070h }}
*{{cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149-56 |year= 1997 |pmid= 9373149 |doi= }}
*{{cite journal | author=Barber RC, Shaw GM, Lammer EJ, ''et al.'' |title=Lack of association between mutations in the folate receptor-alpha gene and spina bifida. |journal=Am. J. Med. Genet. |volume=76 |issue= 4 |pages= 310-7 |year= 1998 |pmid= 9545095 |doi= }}
*{{cite journal | author=Tomassetti A, Bottero F, Mazzi M, ''et al.'' |title=Molecular requirements for attachment of the glycosylphosphatidylinositol anchor to the human alpha folate receptor. |journal=J. Cell. Biochem. |volume=72 |issue= 1 |pages= 111-8 |year= 1999 |pmid= 10025672 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on FUS... {November 19, 2007 12:00:41 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:01:20 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Fusion (involved in t(12;16) in malignant liposarcoma)
| HGNCid = 4010
| Symbol = FUS
| AltSymbols =; CHOP; FUS-CHOP; FUS1; TLS; TLS/CHOP
| OMIM = 137070
| ECnumber =
| Homologene = 3639
| MGIid = 1353633
| GeneAtlas_image1 = PBB_GE_FUS_200959_at_tn.png
| GeneAtlas_image2 = PBB_GE_FUS_217370_x_at_tn.png
| Function = {{GNF_GO|id=GO:0000166 |text = nucleotide binding}} {{GNF_GO|id=GO:0003674 |text = molecular_function}} {{GNF_GO|id=GO:0003676 |text = nucleic acid binding}} {{GNF_GO|id=GO:0003677 |text = DNA binding}} {{GNF_GO|id=GO:0003723 |text = RNA binding}} {{GNF_GO|id=GO:0005515 |text = protein binding}} {{GNF_GO|id=GO:0008270 |text = zinc ion binding}} {{GNF_GO|id=GO:0046872 |text = metal ion binding}}
| Component = {{GNF_GO|id=GO:0005575 |text = cellular_component}} {{GNF_GO|id=GO:0005622 |text = intracellular}} {{GNF_GO|id=GO:0005634 |text = nucleus}}
| Process = {{GNF_GO|id=GO:0008150 |text = biological_process}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 2521
| Hs_Ensembl = ENSG00000089280
| Hs_RefseqProtein = NP_001010850
| Hs_RefseqmRNA = NM_001010850
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 16
| Hs_GenLoc_start = 31098954
| Hs_GenLoc_end = 31110598
| Hs_Uniprot = P35637
| Mm_EntrezGene = 233908
| Mm_Ensembl = ENSMUSG00000030795
| Mm_RefseqmRNA = XM_986259
| Mm_RefseqProtein = XP_991353
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 7
| Mm_GenLoc_start = 127758702
| Mm_GenLoc_end = 127773179
| Mm_Uniprot = Q0VDX4
}}
}}
'''Fusion (involved in t(12;16) in malignant liposarcoma)''', also known as '''FUS''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: FUS fusion (involved in t(12;16) in malignant liposarcoma)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2521| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text =
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Kaplowitz N, Ji C |title=Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulum. |journal=J. Gastroenterol. Hepatol. |volume=21 Suppl 3 |issue= |pages= S7-9 |year= 2007 |pmid= 16958678 |doi= 10.1111/j.1440-1746.2006.04581.x }}
*{{cite journal | author=Eneroth M, Mandahl N, Heim S, ''et al.'' |title=Localization of the chromosomal breakpoints of the t(12;16) in liposarcoma to subbands 12q13.3 and 16p11.2. |journal=Cancer Genet. Cytogenet. |volume=48 |issue= 1 |pages= 101-7 |year= 1990 |pmid= 2372777 |doi= }}
*{{cite journal | author=Rabbitts TH, Forster A, Larson R, Nathan P |title=Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. |journal=Nat. Genet. |volume=4 |issue= 2 |pages= 175-80 |year= 1993 |pmid= 7503811 |doi= 10.1038/ng0693-175 }}
*{{cite journal | author=Panagopoulos I, Mandahl N, Ron D, ''et al.'' |title=Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. |journal=Cancer Res. |volume=54 |issue= 24 |pages= 6500-3 |year= 1995 |pmid= 7987849 |doi= }}
*{{cite journal | author=Ichikawa H, Shimizu K, Hayashi Y, Ohki M |title=An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. |journal=Cancer Res. |volume=54 |issue= 11 |pages= 2865-8 |year= 1994 |pmid= 8187069 |doi= }}
*{{cite journal | author=Crozat A, Aman P, Mandahl N, Ron D |title=Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. |journal=Nature |volume=363 |issue= 6430 |pages= 640-4 |year= 1993 |pmid= 8510758 |doi= 10.1038/363640a0 }}
*{{cite journal | author=Aman P, Panagopoulos I, Lassen C, ''et al.'' |title=Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. |journal=Genomics |volume=37 |issue= 1 |pages= 1-8 |year= 1997 |pmid= 8921363 |doi= 10.1006/geno.1996.0513 }}
*{{cite journal | author=Zinszner H, Sok J, Immanuel D, ''et al.'' |title=TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. |journal=J. Cell. Sci. |volume=110 ( Pt 15) |issue= |pages= 1741-50 |year= 1997 |pmid= 9264461 |doi= }}
*{{cite journal | author=Powers CA, Mathur M, Raaka BM, ''et al.'' |title=TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. |journal=Mol. Endocrinol. |volume=12 |issue= 1 |pages= 4-18 |year= 1998 |pmid= 9440806 |doi= }}
*{{cite journal | author=Hallier M, Lerga A, Barnache S, ''et al.'' |title=The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. |journal=J. Biol. Chem. |volume=273 |issue= 9 |pages= 4838-42 |year= 1998 |pmid= 9478924 |doi= }}
*{{cite journal | author=Zhang D, Paley AJ, Childs G |title=The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. |journal=J. Biol. Chem. |volume=273 |issue= 29 |pages= 18086-91 |year= 1998 |pmid= 9660765 |doi= }}
*{{cite journal | author=Yang L, Embree LJ, Tsai S, Hickstein DD |title=Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. |journal=J. Biol. Chem. |volume=273 |issue= 43 |pages= 27761-4 |year= 1998 |pmid= 9774382 |doi= }}
*{{cite journal | author=Morohoshi F, Ootsuka Y, Arai K, ''et al.'' |title=Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. |journal=Gene |volume=221 |issue= 2 |pages= 191-8 |year= 1998 |pmid= 9795213 |doi= }}
*{{cite journal | author=Bertrand P, Akhmedov AT, Delacote F, ''et al.'' |title=Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. |journal=Oncogene |volume=18 |issue= 31 |pages= 4515-21 |year= 1999 |pmid= 10442642 |doi= 10.1038/sj.onc.1203048 }}
*{{cite journal | author=Baechtold H, Kuroda M, Sok J, ''et al.'' |title=Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. |journal=J. Biol. Chem. |volume=274 |issue= 48 |pages= 34337-42 |year= 1999 |pmid= 10567410 |doi= }}
*{{cite journal | author=Yang L, Embree LJ, Hickstein DD |title=TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. |journal=Mol. Cell. Biol. |volume=20 |issue= 10 |pages= 3345-54 |year= 2000 |pmid= 10779324 |doi= }}
*{{cite journal | author=Husi H, Ward MA, Choudhary JS, ''et al.'' |title=Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. |journal=Nat. Neurosci. |volume=3 |issue= 7 |pages= 661-9 |year= 2000 |pmid= 10862698 |doi= 10.1038/76615 }}
*{{cite journal | author=Uranishi H, Tetsuka T, Yamashita M, ''et al.'' |title=Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. |journal=J. Biol. Chem. |volume=276 |issue= 16 |pages= 13395-401 |year= 2001 |pmid= 11278855 |doi= 10.1074/jbc.M011176200 }}
*{{cite journal | author=Saunders LR, Perkins DJ, Balachandran S, ''et al.'' |title=Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR. |journal=J. Biol. Chem. |volume=276 |issue= 34 |pages= 32300-12 |year= 2001 |pmid= 11438536 |doi= 10.1074/jbc.M104207200 }}
*{{cite journal | author=Lee J, Bedford MT |title=PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. |journal=EMBO Rep. |volume=3 |issue= 3 |pages= 268-73 |year= 2002 |pmid= 11850402 |doi= 10.1093/embo-reports/kvf052 }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on GHRHR... {November 19, 2007 12:02:43 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:03:12 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Growth hormone releasing hormone receptor
| HGNCid = 4266
| Symbol = GHRHR
| AltSymbols =; GHRFR; GHRHRpsv; GRFR
| OMIM = 139191
| ECnumber =
| Homologene = 640
| MGIid = 95710
| GeneAtlas_image1 = PBB_GE_GHRHR_207825_s_at_tn.png
| GeneAtlas_image2 = PBB_GE_GHRHR_211544_s_at_tn.png
| GeneAtlas_image3 = PBB_GE_GHRHR_211545_at_tn.png
| Function = {{GNF_GO|id=GO:0004872 |text = receptor activity}} {{GNF_GO|id=GO:0004930 |text = G-protein coupled receptor activity}} {{GNF_GO|id=GO:0004999 |text = vasoactive intestinal polypeptide receptor activity}} {{GNF_GO|id=GO:0016520 |text = growth hormone-releasing hormone receptor activity}}
| Component = {{GNF_GO|id=GO:0005886 |text = plasma membrane}} {{GNF_GO|id=GO:0016020 |text = membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}}
| Process = {{GNF_GO|id=GO:0001501 |text = skeletal development}} {{GNF_GO|id=GO:0007165 |text = signal transduction}} {{GNF_GO|id=GO:0007186 |text = G-protein coupled receptor protein signaling pathway}} {{GNF_GO|id=GO:0007190 |text = adenylate cyclase activation}} {{GNF_GO|id=GO:0008150 |text = biological_process}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 2692
| Hs_Ensembl = ENSG00000106128
| Hs_RefseqProtein = NP_000814
| Hs_RefseqmRNA = NM_000823
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 7
| Hs_GenLoc_start = 30970161
| Hs_GenLoc_end = 30990114
| Hs_Uniprot = Q02643
| Mm_EntrezGene = 14602
| Mm_Ensembl = ENSMUSG00000004654
| Mm_RefseqmRNA = NM_001003685
| Mm_RefseqProtein = NP_001003685
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 6
| Mm_GenLoc_start = 55305921
| Mm_GenLoc_end = 55318108
| Mm_Uniprot = Q0VB62
}}
}}
'''Growth hormone releasing hormone receptor''', also known as '''GHRHR''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: GHRHR growth hormone releasing hormone receptor| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2692| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = This gene, expressed in the pituitary, encodes a receptor for growth hormone-releasing hormone. Binding of this hormone to the receptor leads to synthesis and release of growth hormone. Mutations in this gene have been associated with isolated growth hormone deficiency (IGHD), also known as Dwarfism of Sindh, a disorder characterized by short stature. Many alternate transcriptional splice variants encoding different isoforms have been described, but only two have been characterized to date.<ref name="entrez">{{cite web | title = Entrez Gene: GHRHR growth hormone releasing hormone receptor| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2692| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Gaylinn BD |title=Molecular and cell biology of the growth hormone-releasing hormone receptor. |journal=Growth Horm. IGF Res. |volume=9 Suppl A |issue= |pages= 37-44 |year= 1999 |pmid= 10429879 |doi= }}
*{{cite journal | author=Lin-Su K, Wajnrajch MP |title=Growth Hormone Releasing Hormone (GHRH) and the GHRH Receptor. |journal=Reviews in endocrine & metabolic disorders |volume=3 |issue= 4 |pages= 313-23 |year= 2003 |pmid= 12424433 |doi= }}
*{{cite journal | author=Mayo KE |title=Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. |journal=Mol. Endocrinol. |volume=6 |issue= 10 |pages= 1734-44 |year= 1992 |pmid= 1333056 |doi= }}
*{{cite journal | author=Squire J, Zhou A, Hassel BA, ''et al.'' |title=Localization of the interferon-induced, 2-5A-dependent RNase gene (RNS4) to human chromosome 1q25. |journal=Genomics |volume=19 |issue= 1 |pages= 174-5 |year= 1994 |pmid= 7514564 |doi= 10.1006/geno.1994.1033 }}
*{{cite journal | author=Hashimoto K, Koga M, Motomura T, ''et al.'' |title=Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. |journal=J. Clin. Endocrinol. Metab. |volume=80 |issue= 10 |pages= 2933-9 |year= 1995 |pmid= 7559877 |doi= }}
*{{cite journal | author=Tang J, Lagacé G, Castagné J, Collu R |title=Identification of human growth hormone-releasing hormone receptor splicing variants. |journal=J. Clin. Endocrinol. Metab. |volume=80 |issue= 8 |pages= 2381-7 |year= 1995 |pmid= 7629234 |doi= }}
*{{cite journal | author=Gaylinn BD, Harrison JK, Zysk JR, ''et al.'' |title=Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. |journal=Mol. Endocrinol. |volume=7 |issue= 1 |pages= 77-84 |year= 1993 |pmid= 7680413 |doi= }}
*{{cite journal | author=Gaylinn BD, von Kap-Herr C, Golden WL, Thorner MO |title=Assignment of the human growth hormone-releasing hormone receptor gene (GHRHR) to 7p14 by in situ hybridization. |journal=Genomics |volume=19 |issue= 1 |pages= 193-5 |year= 1994 |pmid= 8188233 |doi= 10.1006/geno.1994.1045 }}
*{{cite journal | author=Wajnrajch MP, Gertner JM, Harbison MD, ''et al.'' |title=Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. |journal=Nat. Genet. |volume=12 |issue= 1 |pages= 88-90 |year= 1996 |pmid= 8528260 |doi= 10.1038/ng0196-88 }}
*{{cite journal | author=Netchine I, Talon P, Dastot F, ''et al.'' |title=Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. |journal=J. Clin. Endocrinol. Metab. |volume=83 |issue= 2 |pages= 432-6 |year= 1998 |pmid= 9467553 |doi= }}
*{{cite journal | author=Petersenn S, Rasch AC, Heyens M, Schulte HM |title=Structure and regulation of the human growth hormone-releasing hormone receptor gene. |journal=Mol. Endocrinol. |volume=12 |issue= 2 |pages= 233-47 |year= 1998 |pmid= 9482665 |doi= }}
*{{cite journal | author=Maheshwari HG, Silverman BL, Dupuis J, Baumann G |title=Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh. |journal=J. Clin. Endocrinol. Metab. |volume=83 |issue= 11 |pages= 4065-74 |year= 1998 |pmid= 9814493 |doi= }}
*{{cite journal | author=Salvatori R, Hayashida CY, Aguiar-Oliveira MH, ''et al.'' |title=Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. |journal=J. Clin. Endocrinol. Metab. |volume=84 |issue= 3 |pages= 917-23 |year= 1999 |pmid= 10084571 |doi= }}
*{{cite journal | author=Morel G, Gallego R, Boulanger L, ''et al.'' |title=Restricted presence of the growth hormone-releasing hormone receptor to somatotropes in rat and human pituitaries. |journal=Neuroendocrinology |volume=70 |issue= 2 |pages= 128-36 |year= 2000 |pmid= 10461027 |doi= }}
*{{cite journal | author=Rekasi Z, Czompoly T, Schally AV, Halmos G |title=Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=97 |issue= 19 |pages= 10561-6 |year= 2000 |pmid= 10962031 |doi= 10.1073/pnas.180313297 }}
*{{cite journal | author=Salvatori R, Fan X, Phillips JA, ''et al.'' |title=Three new mutations in the gene for the growth hormone (gh)-releasing hormone receptor in familial isolated gh deficiency type ib. |journal=J. Clin. Endocrinol. Metab. |volume=86 |issue= 1 |pages= 273-9 |year= 2001 |pmid= 11232012 |doi= }}
*{{cite journal | author=Kiaris H, Schally AV, Busto R, ''et al.'' |title=Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 1 |pages= 196-200 |year= 2002 |pmid= 11773624 |doi= 10.1073/pnas.012590999 }}
*{{cite journal | author=Salvatori R, Fan X, Mullis PE, ''et al.'' |title=Decreased expression of the GHRH receptor gene due to a mutation in a Pit-1 binding site. |journal=Mol. Endocrinol. |volume=16 |issue= 3 |pages= 450-8 |year= 2002 |pmid= 11875102 |doi= }}
*{{cite journal | author=Plonowski A, Schally AV, Busto R, ''et al.'' |title=Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers. |journal=Peptides |volume=23 |issue= 6 |pages= 1127-33 |year= 2003 |pmid= 12126741 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on GPC3... {November 19, 2007 12:03:12 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:03:45 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Glypican 3
| HGNCid = 4451
| Symbol = GPC3
| AltSymbols =; DGSX; OCI-5; SDYS; SGB; SGBS; SGBS1
| OMIM = 300037
| ECnumber =
| Homologene = 20944
| MGIid = 104903
| GeneAtlas_image1 = PBB_GE_GPC3_209220_at_tn.png
| Function = {{GNF_GO|id=GO:0048503 |text = GPI anchor binding}}
| Component = {{GNF_GO|id=GO:0005578 |text = proteinaceous extracellular matrix}} {{GNF_GO|id=GO:0005887 |text = integral to plasma membrane}} {{GNF_GO|id=GO:0016020 |text = membrane}}
| Process = {{GNF_GO|id=GO:0001658 |text = ureteric bud branching}} {{GNF_GO|id=GO:0008285 |text = negative regulation of cell proliferation}} {{GNF_GO|id=GO:0009887 |text = organ morphogenesis}} {{GNF_GO|id=GO:0030513 |text = positive regulation of BMP signaling pathway}} {{GNF_GO|id=GO:0045926 |text = negative regulation of growth}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 2719
| Hs_Ensembl = ENSG00000147257
| Hs_RefseqProtein = NP_004475
| Hs_RefseqmRNA = NM_004484
| Hs_GenLoc_db =
| Hs_GenLoc_chr = X
| Hs_GenLoc_start = 132497439
| Hs_GenLoc_end = 132947588
| Hs_Uniprot = P51654
| Mm_EntrezGene = 14734
| Mm_Ensembl = ENSMUSG00000055653
| Mm_RefseqmRNA = NM_016697
| Mm_RefseqProtein = NP_057906
| Mm_GenLoc_db =
| Mm_GenLoc_chr = X
| Mm_GenLoc_start = 48517053
| Mm_GenLoc_end = 48858548
| Mm_Uniprot = Q3TWB2
}}
}}
'''Glypican 3''', also known as '''GPC3''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: GPC3 glypican 3| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2719| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome.<ref name="entrez">{{cite web | title = Entrez Gene: GPC3 glypican 3| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2719| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Li M, Squire JA, Weksberg R |title=Overgrowth syndromes and genomic imprinting: from mouse to man. |journal=Clin. Genet. |volume=53 |issue= 3 |pages= 165-70 |year= 1998 |pmid= 9630066 |doi= }}
*{{cite journal | author=Filmus J |title=Glypicans in growth control and cancer. |journal=Glycobiology |volume=11 |issue= 3 |pages= 19R-23R |year= 2001 |pmid= 11320054 |doi= }}
*{{cite journal | author=Filmus J, Shi W, Wong ZM, Wong MJ |title=Identification of a new membrane-bound heparan sulphate proteoglycan. |journal=Biochem. J. |volume=311 ( Pt 2) |issue= |pages= 561-5 |year= 1995 |pmid= 7487896 |doi= }}
*{{cite journal | author=Watanabe K, Yamada H, Yamaguchi Y |title=K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. |journal=J. Cell Biol. |volume=130 |issue= 5 |pages= 1207-18 |year= 1995 |pmid= 7657705 |doi= }}
*{{cite journal | author=Xuan JY, Besner A, Ireland M, ''et al.'' |title=Mapping of Simpson-Golabi-Behmel syndrome to Xq25-q27. |journal=Hum. Mol. Genet. |volume=3 |issue= 1 |pages= 133-7 |year= 1994 |pmid= 7909248 |doi= }}
*{{cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171-4 |year= 1994 |pmid= 8125298 |doi= }}
*{{cite journal | author=Pilia G, Hughes-Benzie RM, MacKenzie A, ''et al.'' |title=Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. |journal=Nat. Genet. |volume=12 |issue= 3 |pages= 241-7 |year= 1996 |pmid= 8589713 |doi= 10.1038/ng0396-241 }}
*{{cite journal | author=Shen T, Sonoda G, Hamid J, ''et al.'' |title=Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization. |journal=Mamm. Genome |volume=8 |issue= 1 |pages= 72 |year= 1997 |pmid= 9021160 |doi= }}
*{{cite journal | author=Lage H, Dietel M |title=Cloning and characterization of human cDNAs encoding a protein with high homology to rat intestinal development protein OCI-5. |journal=Gene |volume=188 |issue= 2 |pages= 151-6 |year= 1997 |pmid= 9133586 |doi= }}
*{{cite journal | author=Huber R, Crisponi L, Mazzarella R, ''et al.'' |title=Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene. |journal=Genomics |volume=45 |issue= 1 |pages= 48-58 |year= 1997 |pmid= 9339360 |doi= 10.1006/geno.1997.4916 }}
*{{cite journal | author=Hsu HC, Cheng W, Lai PL |title=Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. |journal=Cancer Res. |volume=57 |issue= 22 |pages= 5179-84 |year= 1997 |pmid= 9371521 |doi= }}
*{{cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149-56 |year= 1997 |pmid= 9373149 |doi= }}
*{{cite journal | author=Veugelers M, Vermeesch J, Watanabe K, ''et al.'' |title=GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. |journal=Genomics |volume=53 |issue= 1 |pages= 1-11 |year= 1998 |pmid= 9787072 |doi= 10.1006/geno.1998.5465 }}
*{{cite journal | author=Pellegrini M, Pilia G, Pantano S, ''et al.'' |title=Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. |journal=Dev. Dyn. |volume=213 |issue= 4 |pages= 431-9 |year= 1999 |pmid= 9853964 |doi= 10.1002/(SICI)1097-0177(199812)213:4<431::AID-AJA8>3.0.CO;2-7 }}
*{{cite journal | author=Huber R, Mazzarella R, Chen CN, ''et al.'' |title=Glypican 3 and glypican 4 are juxtaposed in Xq26.1. |journal=Gene |volume=225 |issue= 1-2 |pages= 9-16 |year= 1999 |pmid= 9931407 |doi= }}
*{{cite journal | author=Xuan JY, Hughes-Benzie RM, MacKenzie AE |title=A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family. |journal=J. Med. Genet. |volume=36 |issue= 1 |pages= 57-8 |year= 1999 |pmid= 9950367 |doi= }}
*{{cite journal | author=Veugelers M, Cat BD, Muyldermans SY, ''et al.'' |title=Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. |journal=Hum. Mol. Genet. |volume=9 |issue= 9 |pages= 1321-8 |year= 2000 |pmid= 10814714 |doi= }}
*{{cite journal | author=Khan S, Blackburn M, Mao DL, ''et al.'' |title=Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast. |journal=Histol. Histopathol. |volume=16 |issue= 1 |pages= 71-8 |year= 2001 |pmid= 11193214 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on GPX4... {November 19, 2007 12:03:45 AM PST}
- SEARCH REDIRECT: Control Box Found: GPX4 {November 19, 2007 12:05:11 AM PST}
- UPDATE PROTEIN BOX: Updating Protein Box, No errors. {November 19, 2007 12:05:12 AM PST}
- UPDATE SUMMARY: Updating Summary, No Errors. {November 19, 2007 12:05:12 AM PST}
- UPDATE CITATIONS: Updating Citations, No Errors. {November 19, 2007 12:05:12 AM PST}
- UPDATED: Updated protein page: GPX4 {November 19, 2007 12:05:18 AM PST}
- INFO: Beginning work on IL9... {November 19, 2007 12:05:18 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:05:52 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Interleukin 9
| HGNCid = 6029
| Symbol = IL9
| AltSymbols =; HP40; IL-9; P40
| OMIM = 146931
| ECnumber =
| Homologene = 492
| MGIid = 96563
| GeneAtlas_image1 = PBB_GE_IL9_208193_at_tn.png
| Function = {{GNF_GO|id=GO:0005140 |text = interleukin-9 receptor binding}}
| Component = {{GNF_GO|id=GO:0005576 |text = extracellular region}} {{GNF_GO|id=GO:0005615 |text = extracellular space}}
| Process = {{GNF_GO|id=GO:0006954 |text = inflammatory response}} {{GNF_GO|id=GO:0006955 |text = immune response}} {{GNF_GO|id=GO:0007267 |text = cell-cell signaling}} {{GNF_GO|id=GO:0008284 |text = positive regulation of cell proliferation}} {{GNF_GO|id=GO:0045407 |text = positive regulation of interleukin-5 biosynthetic process}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 3578
| Hs_Ensembl = ENSG00000145839
| Hs_RefseqProtein = NP_000581
| Hs_RefseqmRNA = NM_000590
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 5
| Hs_GenLoc_start = 135255834
| Hs_GenLoc_end = 135259415
| Hs_Uniprot = P15248
| Mm_EntrezGene = 16198
| Mm_Ensembl = ENSMUSG00000021538
| Mm_RefseqmRNA = NM_008373
| Mm_RefseqProtein = NP_032399
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 13
| Mm_GenLoc_start = 56488899
| Mm_GenLoc_end = 56491868
| Mm_Uniprot = P15247
}}
}}
'''Interleukin 9''', also known as '''IL9''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: IL9 interleukin 9| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3578| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = The protein encoded by this gene is a cytokine that acts as a regulator of a variety of hematopoietic cells. This cytokine stimulates cell proliferation and prevents apoptosis. It functions through the interleukin 9 receptor (IL9R), which activates different signal transducer and activator (STAT) proteins and thus connects this cytokine to various biological processes. The gene encoding this cytokine has been identified as a candidate gene for asthma. Genetic studies on a mouse model of asthma demonstrated that this cytokine is a determining factor in the pathogenesis of bronchial hyperresponsiveness.<ref name="entrez">{{cite web | title = Entrez Gene: IL9 interleukin 9| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3578| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Renauld JC, Houssiau F, Louahed J, ''et al.'' |title=Interleukin-9. |journal=Adv. Immunol. |volume=54 |issue= |pages= 79-97 |year= 1993 |pmid= 8379467 |doi= }}
*{{cite journal | author=Knoops L, Renauld JC |title=IL-9 and its receptor: from signal transduction to tumorigenesis. |journal=Growth Factors |volume=22 |issue= 4 |pages= 207-15 |year= 2005 |pmid= 15621723 |doi= 10.1080/08977190410001720879 }}
*{{cite journal | author=Modi WS, Pollock DD, Mock BA, ''et al.'' |title=Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization. |journal=Cytogenet. Cell Genet. |volume=57 |issue= 2-3 |pages= 114-6 |year= 1991 |pmid= 1680606 |doi= }}
*{{cite journal | author=Kelleher K, Bean K, Clark SC, ''et al.'' |title=Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cells. |journal=Blood |volume=77 |issue= 7 |pages= 1436-41 |year= 1991 |pmid= 1901233 |doi= }}
*{{cite journal | author=Holbrook ST, Ohls RK, Schibler KR, ''et al.'' |title=Effect of interleukin-9 on clonogenic maturation and cell-cycle status of fetal and adult hematopoietic progenitors. |journal=Blood |volume=77 |issue= 10 |pages= 2129-34 |year= 1991 |pmid= 1903074 |doi= }}
*{{cite journal | author=Merz H, Houssiau FA, Orscheschek K, ''et al.'' |title=Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. |journal=Blood |volume=78 |issue= 5 |pages= 1311-7 |year= 1991 |pmid= 1908723 |doi= }}
*{{cite journal | author=Renauld JC, Goethals A, Houssiau F, ''et al.'' |title=Human P40/IL-9. Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene. |journal=J. Immunol. |volume=144 |issue= 11 |pages= 4235-41 |year= 1990 |pmid= 1971295 |doi= }}
*{{cite journal | author=Renauld JC, Goethals A, Houssiau F, ''et al.'' |title=Cloning and expression of a cDNA for the human homolog of mouse T cell and mast cell growth factor P40. |journal=Cytokine |volume=2 |issue= 1 |pages= 9-12 |year= 1991 |pmid= 2129501 |doi= }}
*{{cite journal | author=Yang YC, Ricciardi S, Ciarletta A, ''et al.'' |title=Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40. |journal=Blood |volume=74 |issue= 6 |pages= 1880-4 |year= 1989 |pmid= 2508790 |doi= }}
*{{cite journal | author=Yin T, Keller SR, Quelle FW, ''et al.'' |title=Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases. |journal=J. Biol. Chem. |volume=270 |issue= 35 |pages= 20497-502 |year= 1995 |pmid= 7544789 |doi= }}
*{{cite journal | author=Postma DS, Bleecker ER, Amelung PJ, ''et al.'' |title=Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy. |journal=N. Engl. J. Med. |volume=333 |issue= 14 |pages= 894-900 |year= 1995 |pmid= 7666875 |doi= }}
*{{cite journal | author=Le Beau MM, Espinosa R, Neuman WL, ''et al.'' |title=Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=90 |issue= 12 |pages= 5484-8 |year= 1993 |pmid= 8516290 |doi= }}
*{{cite journal | author=Demoulin JB, Uyttenhove C, Van Roost E, ''et al.'' |title=A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. |journal=Mol. Cell. Biol. |volume=16 |issue= 9 |pages= 4710-6 |year= 1996 |pmid= 8756628 |doi= }}
*{{cite journal | author=Nicolaides NC, Holroyd KJ, Ewart SL, ''et al.'' |title=Interleukin 9: a candidate gene for asthma. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=94 |issue= 24 |pages= 13175-80 |year= 1998 |pmid= 9371819 |doi= }}
*{{cite journal | author=Demoulin JB, Van Roost E, Stevens M, ''et al.'' |title=Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9. |journal=J. Biol. Chem. |volume=274 |issue= 36 |pages= 25855-61 |year= 1999 |pmid= 10464327 |doi= }}
*{{cite journal | author=Lejeune D, Demoulin JB, Renauld JC |title=Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. |journal=Biochem. J. |volume=353 |issue= Pt 1 |pages= 109-116 |year= 2001 |pmid= 11115404 |doi= }}
*{{cite journal | author=Little FF, Cruikshank WW, Center DM |title=Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells. |journal=Am. J. Respir. Cell Mol. Biol. |volume=25 |issue= 3 |pages= 347-52 |year= 2001 |pmid= 11588013 |doi= }}
*{{cite journal | author=Toda M, Tulic MK, Levitt RC, Hamid Q |title=A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. |journal=J. Allergy Clin. Immunol. |volume=109 |issue= 2 |pages= 246-50 |year= 2002 |pmid= 11842292 |doi= }}
*{{cite journal | author=Pilette C, Ouadrhiri Y, Van Snick J, ''et al.'' |title=IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta. |journal=J. Immunol. |volume=168 |issue= 8 |pages= 4103-11 |year= 2002 |pmid= 11937570 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on IRF2... {November 19, 2007 12:05:52 AM PST}
- SEARCH REDIRECT: Control Box Found: IRF2 {November 19, 2007 12:06:21 AM PST}
- UPDATE PROTEIN BOX: Updating Protein Box, No errors. {November 19, 2007 12:06:22 AM PST}
- SKIP SUMMARY: SKIPPING Summary, No Errors. {November 19, 2007 12:06:22 AM PST}
- UPDATE CITATIONS: Updating Citations, No Errors. {November 19, 2007 12:06:22 AM PST}
- UPDATED: Updated protein page: IRF2 {November 19, 2007 12:06:28 AM PST}
- INFO: Beginning work on IRF7... {November 19, 2007 12:06:28 AM PST}
- SEARCH REDIRECT: Control Box Found: IRF7 {November 19, 2007 12:07:00 AM PST}
- UPDATE PROTEIN BOX: Updating Protein Box, No errors. {November 19, 2007 12:07:03 AM PST}
- UPDATE SUMMARY: Updating Summary, No Errors. {November 19, 2007 12:07:03 AM PST}
- UPDATE CITATIONS: Updating Citations, No Errors. {November 19, 2007 12:07:03 AM PST}
- UPDATED: Updated protein page: IRF7 {November 19, 2007 12:07:10 AM PST}
- INFO: Beginning work on KCNIP3... {November 19, 2007 12:12:35 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:13:07 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Kv channel interacting protein 3, calsenilin
| HGNCid = 15523
| Symbol = KCNIP3
| AltSymbols =; CSEN; DREAM; KCHIP3; MGC18289
| OMIM = 604662
| ECnumber =
| Homologene = 8382
| MGIid = 1929258
| Function = {{GNF_GO|id=GO:0003677 |text = DNA binding}} {{GNF_GO|id=GO:0003714 |text = transcription corepressor activity}} {{GNF_GO|id=GO:0005216 |text = ion channel activity}} {{GNF_GO|id=GO:0005244 |text = voltage-gated ion channel activity}} {{GNF_GO|id=GO:0005267 |text = potassium channel activity}} {{GNF_GO|id=GO:0005509 |text = calcium ion binding}} {{GNF_GO|id=GO:0030955 |text = potassium ion binding}}
| Component = {{GNF_GO|id=GO:0005634 |text = nucleus}} {{GNF_GO|id=GO:0016020 |text = membrane}}
| Process = {{GNF_GO|id=GO:0006350 |text = transcription}} {{GNF_GO|id=GO:0006357 |text = regulation of transcription from RNA polymerase II promoter}} {{GNF_GO|id=GO:0006811 |text = ion transport}} {{GNF_GO|id=GO:0006813 |text = potassium ion transport}} {{GNF_GO|id=GO:0006915 |text = apoptosis}} {{GNF_GO|id=GO:0007165 |text = signal transduction}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 30818
| Hs_Ensembl = ENSG00000115041
| Hs_RefseqProtein = NP_001030086
| Hs_RefseqmRNA = NM_001034914
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 2
| Hs_GenLoc_start = 95326799
| Hs_GenLoc_end = 95415551
| Hs_Uniprot = Q9Y2W7
| Mm_EntrezGene = 56461
| Mm_Ensembl =
| Mm_RefseqmRNA = NM_019789
| Mm_RefseqProtein = NP_062763
| Mm_GenLoc_db =
| Mm_GenLoc_chr =
| Mm_GenLoc_start =
| Mm_GenLoc_end =
| Mm_Uniprot =
}}
}}
'''Kv channel interacting protein 3, calsenilin''', also known as '''KCNIP3''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: KCNIP3 Kv channel interacting protein 3, calsenilin| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=30818| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = This gene encodes a member of the family of voltage-gated potassium (Kv) channel-interacting proteins, which belong to the recoverin branch of the EF-hand superfamily. Members of this family are small calcium binding proteins containing EF-hand-like domains. They are integral subunit components of native Kv4 channel complexes that may regulate A-type currents, and hence neuronal excitability, in response to changes in intracellular calcium. The encoded protein also functions as a calcium-regulated transcriptional repressor, and interacts with presenilins. Alternatively spliced transcript variants encoding different isoforms have been described.<ref name="entrez">{{cite web | title = Entrez Gene: KCNIP3 Kv channel interacting protein 3, calsenilin| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=30818| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Buxbaum JD, Choi EK, Luo Y, ''et al.'' |title=Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. |journal=Nat. Med. |volume=4 |issue= 10 |pages= 1177-81 |year= 1998 |pmid= 9771752 |doi= 10.1038/2673 }}
*{{cite journal | author=Carrión AM, Mellström B, Naranjo JR |title=Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element. |journal=Mol. Cell. Biol. |volume=18 |issue= 12 |pages= 6921-9 |year= 1998 |pmid= 9819380 |doi= }}
*{{cite journal | author=Carrión AM, Link WA, Ledo F, ''et al.'' |title=DREAM is a Ca2+-regulated transcriptional repressor. |journal=Nature |volume=398 |issue= 6722 |pages= 80-4 |year= 1999 |pmid= 10078534 |doi= 10.1038/18044 }}
*{{cite journal | author=An WF, Bowlby MR, Betty M, ''et al.'' |title=Modulation of A-type potassium channels by a family of calcium sensors. |journal=Nature |volume=403 |issue= 6769 |pages= 553-6 |year= 2000 |pmid= 10676964 |doi= 10.1038/35000592 }}
*{{cite journal | author=Leissring MA, Yamasaki TR, Wasco W, ''et al.'' |title=Calsenilin reverses presenilin-mediated enhancement of calcium signaling. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=97 |issue= 15 |pages= 8590-3 |year= 2000 |pmid= 10900016 |doi= }}
*{{cite journal | author=Buxbaum JD, Lilliehook C, Chan JY, ''et al.'' |title=Genomic structure, expression pattern, and chromosomal localization of the human calsenilin gene: no association between an exonic polymorphism and Alzheimer's disease. |journal=Neurosci. Lett. |volume=294 |issue= 3 |pages= 135-8 |year= 2000 |pmid= 11072133 |doi= }}
*{{cite journal | author=Ledo F, Carrión AM, Link WA, ''et al.'' |title=DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription. |journal=Mol. Cell. Biol. |volume=20 |issue= 24 |pages= 9120-6 |year= 2001 |pmid= 11094064 |doi= }}
*{{cite journal | author=Jo DG, Kim MJ, Choi YH, ''et al.'' |title=Pro-apoptotic function of calsenilin/DREAM/KChIP3. |journal=FASEB J. |volume=15 |issue= 3 |pages= 589-91 |year= 2001 |pmid= 11259376 |doi= 10.1096/fj.00-0541fje }}
*{{cite journal | author=Choi EK, Zaidi NF, Miller JS, ''et al.'' |title=Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2. |journal=J. Biol. Chem. |volume=276 |issue= 22 |pages= 19197-204 |year= 2001 |pmid= 11278424 |doi= 10.1074/jbc.M008597200 }}
*{{cite journal | author=Osawa M, Tong KI, Lilliehook C, ''et al.'' |title=Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3. |journal=J. Biol. Chem. |volume=276 |issue= 44 |pages= 41005-13 |year= 2001 |pmid= 11535596 |doi= 10.1074/jbc.M105842200 }}
*{{cite journal | author=Cheng HY, Pitcher GM, Laviolette SR, ''et al.'' |title=DREAM is a critical transcriptional repressor for pain modulation. |journal=Cell |volume=108 |issue= 1 |pages= 31-43 |year= 2002 |pmid= 11792319 |doi= }}
*{{cite journal | author=Lilliehook C, Chan S, Choi EK, ''et al.'' |title=Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling. |journal=Mol. Cell. Neurosci. |volume=19 |issue= 4 |pages= 552-9 |year= 2002 |pmid= 11988022 |doi= 10.1006/mcne.2001.1096 }}
*{{cite journal | author=Takimoto K, Yang EK, Conforti L |title=Palmitoylation of KChIP splicing variants is required for efficient cell surface expression of Kv4.3 channels. |journal=J. Biol. Chem. |volume=277 |issue= 30 |pages= 26904-11 |year= 2002 |pmid= 12006572 |doi= 10.1074/jbc.M203651200 }}
*{{cite journal | author=Ledo F, Kremer L, Mellström B, Naranjo JR |title=Ca2+-dependent block of CREB-CBP transcription by repressor DREAM. |journal=EMBO J. |volume=21 |issue= 17 |pages= 4583-92 |year= 2002 |pmid= 12198160 |doi= }}
*{{cite journal | author=Zaidi NF, Berezovska O, Choi EK, ''et al.'' |title=Biochemical and immunocytochemical characterization of calsenilin in mouse brain. |journal=Neuroscience |volume=114 |issue= 1 |pages= 247-63 |year= 2002 |pmid= 12207970 |doi= }}
*{{cite journal | author=Sanz C, Horita M, Fernandez-Luna JL |title=Fas signaling and blockade of Bcr-Abl kinase induce apoptotic Hrk protein via DREAM inhibition in human leukemia cells. |journal=Haematologica |volume=87 |issue= 9 |pages= 903-7 |year= 2004 |pmid= 12217801 |doi= }}
*{{cite journal | author=Schrader LA, Anderson AE, Mayne A, ''et al.'' |title=PKA modulation of Kv4.2-encoded A-type potassium channels requires formation of a supramolecular complex. |journal=J. Neurosci. |volume=22 |issue= 23 |pages= 10123-33 |year= 2002 |pmid= 12451113 |doi= }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal | author=Hong YM, Jo DG, Lee MC, ''et al.'' |title=Reduced expression of calsenilin/DREAM/KChIP3 in the brains of kainic acid-induced seizure and epilepsy patients. |journal=Neurosci. Lett. |volume=340 |issue= 1 |pages= 33-6 |year= 2003 |pmid= 12648752 |doi= }}
*{{cite journal | author=Shibata R, Misonou H, Campomanes CR, ''et al.'' |title=A fundamental role for KChIPs in determining the molecular properties and trafficking of Kv4.2 potassium channels. |journal=J. Biol. Chem. |volume=278 |issue= 38 |pages= 36445-54 |year= 2003 |pmid= 12829703 |doi= 10.1074/jbc.M306142200 }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on KCNQ3... {November 19, 2007 12:07:10 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:07:38 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Potassium voltage-gated channel, KQT-like subfamily, member 3
| HGNCid = 6297
| Symbol = KCNQ3
| AltSymbols =; BFNC2; EBN2; KV7.3
| OMIM = 602232
| ECnumber =
| Homologene = 20949
| MGIid = 1336181
| GeneAtlas_image1 = PBB_GE_KCNQ3_206573_at_tn.png
| Function = {{GNF_GO|id=GO:0005216 |text = ion channel activity}} {{GNF_GO|id=GO:0005249 |text = voltage-gated potassium channel activity}} {{GNF_GO|id=GO:0030955 |text = potassium ion binding}}
| Component = {{GNF_GO|id=GO:0005624 |text = membrane fraction}} {{GNF_GO|id=GO:0008076 |text = voltage-gated potassium channel complex}} {{GNF_GO|id=GO:0016020 |text = membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}}
| Process = {{GNF_GO|id=GO:0006811 |text = ion transport}} {{GNF_GO|id=GO:0006813 |text = potassium ion transport}} {{GNF_GO|id=GO:0007268 |text = synaptic transmission}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 3786
| Hs_Ensembl = ENSG00000184156
| Hs_RefseqProtein = NP_004510
| Hs_RefseqmRNA = NM_004519
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 8
| Hs_GenLoc_start = 133210691
| Hs_GenLoc_end = 133561961
| Hs_Uniprot = O43525
| Mm_EntrezGene = 110862
| Mm_Ensembl = ENSMUSG00000056258
| Mm_RefseqmRNA = NM_152923
| Mm_RefseqProtein = NP_690887
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 15
| Mm_GenLoc_start = 65824844
| Mm_GenLoc_end = 66115893
| Mm_Uniprot = Q14B66
}}
}}
'''Potassium voltage-gated channel, KQT-like subfamily, member 3''', also known as '''KCNQ3''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: KCNQ3 potassium voltage-gated channel, KQT-like subfamily, member 3| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3786| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and one of two related proteins encoded by the KCNQ2 and KCNQ5 genes, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2).<ref name="entrez">{{cite web | title = Entrez Gene: KCNQ3 potassium voltage-gated channel, KQT-like subfamily, member 3| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3786| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Gutman GA, Chandy KG, Grissmer S, ''et al.'' |title=International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. |journal=Pharmacol. Rev. |volume=57 |issue= 4 |pages= 473-508 |year= 2006 |pmid= 16382104 |doi= 10.1124/pr.57.4.10 }}
*{{cite journal | author=Ryan SG, Wiznitzer M, Hollman C, ''et al.'' |title=Benign familial neonatal convulsions: evidence for clinical and genetic heterogeneity. |journal=Ann. Neurol. |volume=29 |issue= 5 |pages= 469-73 |year= 1991 |pmid= 1859177 |doi= 10.1002/ana.410290504 }}
*{{cite journal | author=Lewis TB, Leach RJ, Ward K, ''et al.'' |title=Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. |journal=Am. J. Hum. Genet. |volume=53 |issue= 3 |pages= 670-5 |year= 1993 |pmid= 8102508 |doi= }}
*{{cite journal | author=Charlier C, Singh NA, Ryan SG, ''et al.'' |title=A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. |journal=Nat. Genet. |volume=18 |issue= 1 |pages= 53-5 |year= 1998 |pmid= 9425900 |doi= 10.1038/ng0198-53 }}
*{{cite journal | author=Yang WP, Levesque PC, Little WA, ''et al.'' |title=Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. |journal=J. Biol. Chem. |volume=273 |issue= 31 |pages= 19419-23 |year= 1998 |pmid= 9677360 |doi= }}
*{{cite journal | author=Wang HS, Pan Z, Shi W, ''et al.'' |title=KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. |journal=Science |volume=282 |issue= 5395 |pages= 1890-3 |year= 1998 |pmid= 9836639 |doi= }}
*{{cite journal | author=Schroeder BC, Kubisch C, Stein V, Jentsch TJ |title=Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. |journal=Nature |volume=396 |issue= 6712 |pages= 687-90 |year= 1999 |pmid= 9872318 |doi= 10.1038/25367 }}
*{{cite journal | author=Kubisch C, Schroeder BC, Friedrich T, ''et al.'' |title=KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. |journal=Cell |volume=96 |issue= 3 |pages= 437-46 |year= 1999 |pmid= 10025409 |doi= }}
*{{cite journal | author=Selyanko AA, Hadley JK, Wood IC, ''et al.'' |title=Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell. |journal=J. Neurosci. |volume=19 |issue= 18 |pages= 7742-56 |year= 1999 |pmid= 10479678 |doi= }}
*{{cite journal | author=Shapiro MS, Roche JP, Kaftan EJ, ''et al.'' |title=Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current. |journal=J. Neurosci. |volume=20 |issue= 5 |pages= 1710-21 |year= 2000 |pmid= 10684873 |doi= }}
*{{cite journal | author=Rundfeldt C, Netzer R |title=The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. |journal=Neurosci. Lett. |volume=282 |issue= 1-2 |pages= 73-6 |year= 2000 |pmid= 10713399 |doi= }}
*{{cite journal | author=Selyanko AA, Hadley JK, Wood IC, ''et al.'' |title=Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors. |journal=J. Physiol. (Lond.) |volume=522 Pt 3 |issue= |pages= 349-55 |year= 2000 |pmid= 10713961 |doi= }}
*{{cite journal | author=Cooper EC, Aldape KD, Abosch A, ''et al.'' |title=Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=97 |issue= 9 |pages= 4914-9 |year= 2000 |pmid= 10781098 |doi= 10.1073/pnas.090092797 }}
*{{cite journal | author=Schwake M, Pusch M, Kharkovets T, Jentsch TJ |title=Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy. |journal=J. Biol. Chem. |volume=275 |issue= 18 |pages= 13343-8 |year= 2000 |pmid= 10788442 |doi= }}
*{{cite journal | author=Hirose S, Zenri F, Akiyoshi H, ''et al.'' |title=A novel mutation of KCNQ3 (c.925T-->C) in a Japanese family with benign familial neonatal convulsions. |journal=Ann. Neurol. |volume=47 |issue= 6 |pages= 822-6 |year= 2000 |pmid= 10852552 |doi= }}
*{{cite journal | author=Main MJ, Cryan JE, Dupere JR, ''et al.'' |title=Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. |journal=Mol. Pharmacol. |volume=58 |issue= 2 |pages= 253-62 |year= 2000 |pmid= 10908292 |doi= }}
*{{cite journal | author=Wickenden AD, Yu W, Zou A, ''et al.'' |title=Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. |journal=Mol. Pharmacol. |volume=58 |issue= 3 |pages= 591-600 |year= 2000 |pmid= 10953053 |doi= }}
*{{cite journal | author=Tinel N, Diochot S, Lauritzen I, ''et al.'' |title=M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit. |journal=FEBS Lett. |volume=480 |issue= 2-3 |pages= 137-41 |year= 2000 |pmid= 11034315 |doi= }}
*{{cite journal | author=Wickenden AD, Zou A, Wagoner PK, Jegla T |title=Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells. |journal=Br. J. Pharmacol. |volume=132 |issue= 2 |pages= 381-4 |year= 2001 |pmid= 11159685 |doi= 10.1038/sj.bjp.0703861 }}
*{{cite journal | author=Yus-Najera E, Santana-Castro I, Villarroel A |title=The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels. |journal=J. Biol. Chem. |volume=277 |issue= 32 |pages= 28545-53 |year= 2002 |pmid= 12032157 |doi= 10.1074/jbc.M204130200 }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on KLRD1... {November 19, 2007 12:07:38 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:08:04 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image = PBB_Protein_KLRD1_image.jpg
| image_source = [[Protein_Data_Bank|PDB]] rendering based on 1b6e.
| PDB = {{PDB2|1b6e}}
| Name = Killer cell lectin-like receptor subfamily D, member 1
| HGNCid = 6378
| Symbol = KLRD1
| AltSymbols =; CD94
| OMIM = 602894
| ECnumber =
| Homologene = 1705
| MGIid = 1196275
| GeneAtlas_image1 = PBB_GE_KLRD1_207795_s_at_tn.png
| GeneAtlas_image2 = PBB_GE_KLRD1_207796_x_at_tn.png
| GeneAtlas_image3 = PBB_GE_KLRD1_210606_x_at_tn.png
| Function = {{GNF_GO|id=GO:0004872 |text = receptor activity}} {{GNF_GO|id=GO:0004888 |text = transmembrane receptor activity}} {{GNF_GO|id=GO:0005529 |text = sugar binding}}
| Component = {{GNF_GO|id=GO:0005886 |text = plasma membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}}
| Process = {{GNF_GO|id=GO:0007166 |text = cell surface receptor linked signal transduction}} {{GNF_GO|id=GO:0019735 |text = antimicrobial humoral response}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 3824
| Hs_Ensembl = ENSG00000134539
| Hs_RefseqProtein = NP_002253
| Hs_RefseqmRNA = NM_002262
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 12
| Hs_GenLoc_start = 10351816
| Hs_GenLoc_end = 10359983
| Hs_Uniprot = Q13241
| Mm_EntrezGene = 16643
| Mm_Ensembl = ENSMUSG00000030165
| Mm_RefseqmRNA = NM_010654
| Mm_RefseqProtein = NP_034784
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 6
| Mm_GenLoc_start = 129559176
| Mm_GenLoc_end = 129564465
| Mm_Uniprot =
}}
}}
'''Killer cell lectin-like receptor subfamily D, member 1''', also known as '''KLRD1''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: KLRD1 killer cell lectin-like receptor subfamily D, member 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3824| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = Natural killer (NK) cells are a distinct lineage of lymphocytes that mediate cytotoxic activity and secrete cytokines upon immune stimulation. Several genes of the C-type lectin superfamily, including members of the NKG2 family, are expressed by NK cells and may be involved in the regulation of NK cell function. KLRD1 (CD94) is an antigen preferentially expressed on NK cells and is classified as a type II membrane protein because it has an external C terminus. KLRD1 has two alternatively spliced variants that differ in the presence or absence of exon 2 sequence.<ref name="entrez">{{cite web | title = Entrez Gene: KLRD1 killer cell lectin-like receptor subfamily D, member 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3824| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Chang C, Rodríguez A, Carretero M, ''et al.'' |title=Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. |journal=Eur. J. Immunol. |volume=25 |issue= 9 |pages= 2433-7 |year= 1995 |pmid= 7589107 |doi= }}
*{{cite journal | author=Moretta A, Vitale M, Sivori S, ''et al.'' |title=Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. |journal=J. Exp. Med. |volume=180 |issue= 2 |pages= 545-55 |year= 1994 |pmid= 8046333 |doi= }}
*{{cite journal | author=Phillips JH, Chang C, Mattson J, ''et al.'' |title=CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. |journal=Immunity |volume=5 |issue= 2 |pages= 163-72 |year= 1996 |pmid= 8769479 |doi= }}
*{{cite journal | author=Lazetic S, Chang C, Houchins JP, ''et al.'' |title=Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. |journal=J. Immunol. |volume=157 |issue= 11 |pages= 4741-5 |year= 1996 |pmid= 8943374 |doi= }}
*{{cite journal | author=Brooks AG, Posch PE, Scorzelli CJ, ''et al.'' |title=NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. |journal=J. Exp. Med. |volume=185 |issue= 4 |pages= 795-800 |year= 1997 |pmid= 9034158 |doi= }}
*{{cite journal | author=Mandelboim O, Pazmany L, Davis DM, ''et al.'' |title=Multiple receptors for HLA-G on human natural killer cells. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=94 |issue= 26 |pages= 14666-70 |year= 1998 |pmid= 9405670 |doi= }}
*{{cite journal | author=Rodríguez A, Carretero M, Glienke J, ''et al.'' |title=Structure of the human CD94 C-type lectin gene. |journal=Immunogenetics |volume=47 |issue= 4 |pages= 305-9 |year= 1998 |pmid= 9472066 |doi= }}
*{{cite journal | author=Le Dréan E, Vély F, Olcese L, ''et al.'' |title=Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. |journal=Eur. J. Immunol. |volume=28 |issue= 1 |pages= 264-76 |year= 1998 |pmid= 9485206 |doi= }}
*{{cite journal | author=Braud VM, Allan DS, O'Callaghan CA, ''et al.'' |title=HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. |journal=Nature |volume=391 |issue= 6669 |pages= 795-9 |year= 1998 |pmid= 9486650 |doi= 10.1038/35869 }}
*{{cite journal | author=Plougastel B, Trowsdale J |title=Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes. |journal=Genomics |volume=49 |issue= 2 |pages= 193-9 |year= 1998 |pmid= 9598306 |doi= 10.1006/geno.1997.5197 }}
*{{cite journal | author=Furukawa H, Yabe T, Watanabe K, ''et al.'' |title=An alternatively spliced form of the human CD94 gene. |journal=Immunogenetics |volume=48 |issue= 1 |pages= 87-8 |year= 1998 |pmid= 9601951 |doi= }}
*{{cite journal | author=Lanier LL, Corliss B, Wu J, Phillips JH |title=Association of DAP12 with activating CD94/NKG2C NK cell receptors. |journal=Immunity |volume=8 |issue= 6 |pages= 693-701 |year= 1998 |pmid= 9655483 |doi= }}
*{{cite journal | author=Vance RE, Kraft JR, Altman JD, ''et al.'' |title=Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). |journal=J. Exp. Med. |volume=188 |issue= 10 |pages= 1841-8 |year= 1999 |pmid= 9815261 |doi= }}
*{{cite journal | author=Brooks AG, Borrego F, Posch PE, ''et al.'' |title=Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. |journal=J. Immunol. |volume=162 |issue= 1 |pages= 305-13 |year= 1999 |pmid= 9886400 |doi= }}
*{{cite journal | author=Boyington JC, Riaz AN, Patamawenu A, ''et al.'' |title=Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. |journal=Immunity |volume=10 |issue= 1 |pages= 75-82 |year= 1999 |pmid= 10023772 |doi= }}
*{{cite journal | author=Bellón T, Heredia AB, Llano M, ''et al.'' |title=Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. |journal=J. Immunol. |volume=162 |issue= 7 |pages= 3996-4002 |year= 1999 |pmid= 10201920 |doi= }}
*{{cite journal | author=Ding Y, Sumitran S, Holgersson J |title=Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells. |journal=Scand. J. Immunol. |volume=49 |issue= 5 |pages= 459-65 |year= 1999 |pmid= 10320637 |doi= }}
*{{cite journal | author=Romero P, Ortega C, Palma A, ''et al.'' |title=Expression of CD94 and NKG2 molecules on human CD4(+) T cells in response to CD3-mediated stimulation. |journal=J. Leukoc. Biol. |volume=70 |issue= 2 |pages= 219-24 |year= 2001 |pmid= 11493613 |doi= }}
*{{cite journal | author=Shum BP, Flodin LR, Muir DG, ''et al.'' |title=Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. |journal=J. Immunol. |volume=168 |issue= 1 |pages= 240-52 |year= 2002 |pmid= 11751968 |doi= }}
*{{cite journal | author=Terrazzano G, Zanzi D, Palomba C, ''et al.'' |title=Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors. |journal=J. Leukoc. Biol. |volume=72 |issue= 2 |pages= 305-11 |year= 2002 |pmid= 12149421 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on LAMA2... {November 19, 2007 12:08:04 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:08:29 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Laminin, alpha 2 (merosin, congenital muscular dystrophy)
| HGNCid = 6482
| Symbol = LAMA2
| AltSymbols =; LAMM
| OMIM = 156225
| ECnumber =
| Homologene = 37306
| MGIid = 99912
| GeneAtlas_image1 = PBB_GE_LAMA2_205116_at_tn.png
| GeneAtlas_image2 = PBB_GE_LAMA2_213519_s_at_tn.png
| GeneAtlas_image3 = PBB_GE_LAMA2_216840_s_at_tn.png
| Function = {{GNF_GO|id=GO:0005102 |text = receptor binding}} {{GNF_GO|id=GO:0005198 |text = structural molecule activity}}
| Component = {{GNF_GO|id=GO:0005604 |text = basement membrane}} {{GNF_GO|id=GO:0005606 |text = laminin-1 complex}} {{GNF_GO|id=GO:0031012 |text = extracellular matrix}}
| Process = {{GNF_GO|id=GO:0007517 |text = muscle development}} {{GNF_GO|id=GO:0030155 |text = regulation of cell adhesion}} {{GNF_GO|id=GO:0030334 |text = regulation of cell migration}} {{GNF_GO|id=GO:0045995 |text = regulation of embryonic development}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 3908
| Hs_Ensembl = ENSG00000196569
| Hs_RefseqProtein = NP_000417
| Hs_RefseqmRNA = NM_000426
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 6
| Hs_GenLoc_start = 129246035
| Hs_GenLoc_end = 129879407
| Hs_Uniprot = P24043
| Mm_EntrezGene = 16773
| Mm_Ensembl = ENSMUSG00000019899
| Mm_RefseqmRNA = NM_008481
| Mm_RefseqProtein = NP_032507
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 10
| Mm_GenLoc_start = 26670815
| Mm_GenLoc_end = 27306267
| Mm_Uniprot = Q8C9J2
}}
}}
'''Laminin, alpha 2 (merosin, congenital muscular dystrophy)''', also known as '''LAMA2''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: LAMA2 laminin, alpha 2 (merosin, congenital muscular dystrophy)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3908| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene.<ref name="entrez">{{cite web | title = Entrez Gene: LAMA2 laminin, alpha 2 (merosin, congenital muscular dystrophy)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3908| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Timpl R |title=Macromolecular organization of basement membranes. |journal=Curr. Opin. Cell Biol. |volume=8 |issue= 5 |pages= 618-24 |year= 1997 |pmid= 8939648 |doi= }}
*{{cite journal | author=Belkin AM, Stepp MA |title=Integrins as receptors for laminins. |journal=Microsc. Res. Tech. |volume=51 |issue= 3 |pages= 280-301 |year= 2000 |pmid= 11054877 |doi= 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O }}
*{{cite journal | author=Jones KJ, Morgan G, Johnston H, ''et al.'' |title=The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. |journal=J. Med. Genet. |volume=38 |issue= 10 |pages= 649-57 |year= 2002 |pmid= 11584042 |doi= }}
*{{cite journal | author=Ehrig K, Leivo I, Argraves WS, ''et al.'' |title=Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=87 |issue= 9 |pages= 3264-8 |year= 1990 |pmid= 2185464 |doi= }}
*{{cite journal | author=Hori H, Kanamori T, Mizuta T, ''et al.'' |title=Human laminin M chain: epitope analysis of its monoclonal antibodies by immunoscreening of cDNA clones and tissue expression. |journal=J. Biochem. |volume=116 |issue= 6 |pages= 1212-9 |year= 1995 |pmid= 7535762 |doi= }}
*{{cite journal | author=Helbling-Leclerc A, Zhang X, Topaloglu H, ''et al.'' |title=Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. |journal=Nat. Genet. |volume=11 |issue= 2 |pages= 216-8 |year= 1995 |pmid= 7550355 |doi= 10.1038/ng1095-216 }}
*{{cite journal | author=Yamada H, Shimizu T, Tanaka T, ''et al.'' |title=Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. |journal=FEBS Lett. |volume=352 |issue= 1 |pages= 49-53 |year= 1994 |pmid= 7925941 |doi= }}
*{{cite journal | author=Vuolteenaho R, Nissinen M, Sainio K, ''et al.'' |title=Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. |journal=J. Cell Biol. |volume=124 |issue= 3 |pages= 381-94 |year= 1994 |pmid= 8294519 |doi= }}
*{{cite journal | author=Bonaldo MF, Lennon G, Soares MB |title=Normalization and subtraction: two approaches to facilitate gene discovery. |journal=Genome Res. |volume=6 |issue= 9 |pages= 791-806 |year= 1997 |pmid= 8889548 |doi= }}
*{{cite journal | author=Zhang X, Vuolteenaho R, Tryggvason K |title=Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. |journal=J. Biol. Chem. |volume=271 |issue= 44 |pages= 27664-9 |year= 1996 |pmid= 8910357 |doi= }}
*{{cite journal | author=Squarzoni S, Villanova M, Sabatelli P, ''et al.'' |title=Intracellular detection of laminin alpha 2 chain in skin by electron microscopy immunocytochemistry: comparison between normal and laminin alpha 2 chain deficient subjects. |journal=Neuromuscul. Disord. |volume=7 |issue= 2 |pages= 91-8 |year= 1997 |pmid= 9131649 |doi= }}
*{{cite journal | author=Allamand V, Sunada Y, Salih MA, ''et al.'' |title=Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. |journal=Hum. Mol. Genet. |volume=6 |issue= 5 |pages= 747-52 |year= 1997 |pmid= 9158149 |doi= }}
*{{cite journal | author=Durkin ME, Loechel F, Mattei MG, ''et al.'' |title=Tissue-specific expression of the human laminin alpha5-chain, and mapping of the gene to human chromosome 20q13.2-13.3 and to distal mouse chromosome 2 near the locus for the ragged (Ra) mutation. |journal=FEBS Lett. |volume=411 |issue= 2-3 |pages= 296-300 |year= 1997 |pmid= 9271224 |doi= }}
*{{cite journal | author=Mrowiec T, Melchar C, Górski A |title=HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium. |journal=Arch. Immunol. Ther. Exp. (Warsz.) |volume=45 |issue= 2-3 |pages= 255-9 |year= 1998 |pmid= 9597096 |doi= }}
*{{cite journal | author=Koch M, Olson PF, Albus A, ''et al.'' |title=Characterization and expression of the laminin gamma3 chain: a novel, non-basement membrane-associated, laminin chain. |journal=J. Cell Biol. |volume=145 |issue= 3 |pages= 605-18 |year= 1999 |pmid= 10225960 |doi= }}
*{{cite journal | author=Kuang W, Xu H, Vilquin JT, Engvall E |title=Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency. |journal=Lab. Invest. |volume=79 |issue= 12 |pages= 1601-13 |year= 2000 |pmid= 10616210 |doi= }}
*{{cite journal | author=Pegoraro E, Fanin M, Trevisan CP, ''et al.'' |title=A novel laminin alpha2 isoform in severe laminin alpha2 deficient congenital muscular dystrophy. |journal=Neurology |volume=55 |issue= 8 |pages= 1128-34 |year= 2000 |pmid= 11071490 |doi= }}
*{{cite journal | author=McArthur CP, Wang Y, Heruth D, Gustafson S |title=Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53. |journal=Arch. Oral Biol. |volume=46 |issue= 6 |pages= 545-55 |year= 2001 |pmid= 11311202 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on LMAN1... {November 19, 2007 12:08:29 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:09:12 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image = PBB_Protein_LMAN1_image.jpg
| image_source = [[Protein_Data_Bank|PDB]] rendering based on 1r1z.
| PDB = {{PDB2|1r1z}}
| Name = Lectin, mannose-binding, 1
| HGNCid = 6631
| Symbol = LMAN1
| AltSymbols =; ERGIC-53; ERGIC53; F5F8D; FMFD1; MCFD1; MR60; gp58
| OMIM = 601567
| ECnumber =
| Homologene = 4070
| MGIid = 1917611
| GeneAtlas_image1 = PBB_GE_LMAN1_203293_s_at_tn.png
| GeneAtlas_image2 = PBB_GE_LMAN1_203294_s_at_tn.png
| Function = {{GNF_GO|id=GO:0005529 |text = sugar binding}} {{GNF_GO|id=GO:0005537 |text = mannose binding}} {{GNF_GO|id=GO:0051082 |text = unfolded protein binding}}
| Component = {{GNF_GO|id=GO:0000139 |text = Golgi membrane}} {{GNF_GO|id=GO:0005783 |text = endoplasmic reticulum}} {{GNF_GO|id=GO:0005789 |text = endoplasmic reticulum membrane}} {{GNF_GO|id=GO:0005793 |text = ER-Golgi intermediate compartment}} {{GNF_GO|id=GO:0005794 |text = Golgi apparatus}} {{GNF_GO|id=GO:0016020 |text = membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}} {{GNF_GO|id=GO:0030017 |text = sarcomere}}
| Process = {{GNF_GO|id=GO:0006457 |text = protein folding}} {{GNF_GO|id=GO:0006888 |text = ER to Golgi vesicle-mediated transport}} {{GNF_GO|id=GO:0007596 |text = blood coagulation}} {{GNF_GO|id=GO:0015031 |text = protein transport}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 3998
| Hs_Ensembl = ENSG00000074695
| Hs_RefseqProtein = NP_005561
| Hs_RefseqmRNA = NM_005570
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 18
| Hs_GenLoc_start = 55148088
| Hs_GenLoc_end = 55177463
| Hs_Uniprot = P49257
| Mm_EntrezGene = 70361
| Mm_Ensembl = ENSMUSG00000041891
| Mm_RefseqmRNA = NM_027400
| Mm_RefseqProtein = NP_081676
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 18
| Mm_GenLoc_start = 66106123
| Mm_GenLoc_end = 66127981
| Mm_Uniprot = Q3U944
}}
}}
'''Lectin, mannose-binding, 1''', also known as '''LMAN1''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: LMAN1 lectin, mannose-binding, 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3998| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = The protein encoded by this gene is a type I integral membrane protein localized in the intermediate region between the endoplasmic reticulum and the Golgi, presumably recycling between the two compartments. The protein is a mannose-specific lectin and is a member of a novel family of plant lectin homologs in the secretory pathway of animal cells. Mutations in the gene are associated with a coagulation defect. Using positional cloning, the gene was identified as the disease gene leading to combined factor V-factor VIII deficiency, a rare, autosomal recessive disorder in which both coagulation factors V and VIII are diminished.<ref name="entrez">{{cite web | title = Entrez Gene: LMAN1 lectin, mannose-binding, 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3998| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Botos I, Wlodawer A |title=Proteins that bind high-mannose sugars of the HIV envelope. |journal=Prog. Biophys. Mol. Biol. |volume=88 |issue= 2 |pages= 233-82 |year= 2005 |pmid= 15572157 |doi= 10.1016/j.pbiomolbio.2004.05.001 }}
*{{cite journal | author=Arar C, Carpentier V, Le Caer JP, ''et al.'' |title=ERGIC-53, a membrane protein of the endoplasmic reticulum-Golgi intermediate compartment, is identical to MR60, an intracellular mannose-specific lectin of myelomonocytic cells. |journal=J. Biol. Chem. |volume=270 |issue= 8 |pages= 3551-3 |year= 1995 |pmid= 7876089 |doi= }}
*{{cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171-4 |year= 1994 |pmid= 8125298 |doi= }}
*{{cite journal | author=Fiedler K, Simons K |title=A putative novel class of animal lectins in the secretory pathway homologous to leguminous lectins. |journal=Cell |volume=77 |issue= 5 |pages= 625-6 |year= 1994 |pmid= 8205612 |doi= }}
*{{cite journal | author=Schindler R, Itin C, Zerial M, ''et al.'' |title=ERGIC-53, a membrane protein of the ER-Golgi intermediate compartment, carries an ER retention motif. |journal=Eur. J. Cell Biol. |volume=61 |issue= 1 |pages= 1-9 |year= 1993 |pmid= 8223692 |doi= }}
*{{cite journal | author=Haurum JS, Thiel S, Jones IM, ''et al.'' |title=Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. |journal=AIDS |volume=7 |issue= 10 |pages= 1307-13 |year= 1994 |pmid= 8267903 |doi= }}
*{{cite journal | author=Senaldi G, Davies ET, Mahalingam M, ''et al.'' |title=Circulating levels of mannose binding protein in human immunodeficiency virus infection. |journal=J. Infect. |volume=31 |issue= 2 |pages= 145-8 |year= 1996 |pmid= 8666845 |doi= }}
*{{cite journal | author=Arar C, Mignon C, Mattei M, ''et al.'' |title=Mapping of the MR60/ERGIC-53 gene to human chromosome 18q21.3-18q22 by in situ hybridization. |journal=Mamm. Genome |volume=7 |issue= 10 |pages= 791-2 |year= 1997 |pmid= 8854877 |doi= }}
*{{cite journal | author=Neerman-Arbez M, Antonarakis SE, Blouin JL, ''et al.'' |title=The locus for combined factor V-factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103. |journal=Am. J. Hum. Genet. |volume=61 |issue= 1 |pages= 143-50 |year= 1997 |pmid= 9245995 |doi= }}
*{{cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149-56 |year= 1997 |pmid= 9373149 |doi= }}
*{{cite journal | author=Nichols WC, Seligsohn U, Zivelin A, ''et al.'' |title=Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. |journal=Cell |volume=93 |issue= 1 |pages= 61-70 |year= 1998 |pmid= 9546392 |doi= }}
*{{cite journal | author=Nichols WC, Terry VH, Wheatley MA, ''et al.'' |title=ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. |journal=Blood |volume=93 |issue= 7 |pages= 2261-6 |year= 1999 |pmid= 10090935 |doi= }}
*{{cite journal | author=Saifuddin M, Hart ML, Gewurz H, ''et al.'' |title=Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. |journal=J. Gen. Virol. |volume=81 |issue= Pt 4 |pages= 949-55 |year= 2000 |pmid= 10725420 |doi= }}
*{{cite journal | author=Harris RA, Yang A, Stein RC, ''et al.'' |title=Cluster analysis of an extensive human breast cancer cell line protein expression map database. |journal=Proteomics |volume=2 |issue= 2 |pages= 212-23 |year= 2002 |pmid= 11840567 |doi= }}
*{{cite journal | author=Jüliger S, Kremsner PG, Alpers MP, ''et al.'' |title=Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New Guinea. |journal=Mutat. Res. |volume=505 |issue= 1-2 |pages= 87-91 |year= 2002 |pmid= 12175909 |doi= }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal | author=Hart ML, Saifuddin M, Uemura K, ''et al.'' |title=High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. |journal=AIDS Res. Hum. Retroviruses |volume=18 |issue= 17 |pages= 1311-7 |year= 2003 |pmid= 12487819 |doi= 10.1089/088922202320886352 }}
*{{cite journal | author=Hart ML, Saifuddin M, Spear GT |title=Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin. |journal=J. Gen. Virol. |volume=84 |issue= Pt 2 |pages= 353-60 |year= 2003 |pmid= 12560567 |doi= }}
*{{cite journal | author=Gevaert K, Goethals M, Martens L, ''et al.'' |title=Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. |journal=Nat. Biotechnol. |volume=21 |issue= 5 |pages= 566-9 |year= 2004 |pmid= 12665801 |doi= 10.1038/nbt810 }}
*{{cite journal | author=García-Laorden MI, Rúa-Figueroa I, Pérez-Aciego P, ''et al.'' |title=Mannose binding lectin polymorphisms as a disease-modulating factor in women with systemic lupus erythematosus from Canary Islands, Spain. |journal=J. Rheumatol. |volume=30 |issue= 4 |pages= 740-6 |year= 2003 |pmid= 12672193 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on LY96... {November 19, 2007 12:11:38 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:12:02 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Lymphocyte antigen 96
| HGNCid = 17156
| Symbol = LY96
| AltSymbols =; MD-2
| OMIM = 605243
| ECnumber =
| Homologene = 9109
| MGIid = 1341909
| GeneAtlas_image1 = PBB_GE_LY96_206584_at_tn.png
| Function = {{GNF_GO|id=GO:0015026 |text = coreceptor activity}}
| Component = {{GNF_GO|id=GO:0005886 |text = plasma membrane}}
| Process = {{GNF_GO|id=GO:0006954 |text = inflammatory response}} {{GNF_GO|id=GO:0006955 |text = immune response}} {{GNF_GO|id=GO:0006968 |text = cellular defense response}} {{GNF_GO|id=GO:0007166 |text = cell surface receptor linked signal transduction}} {{GNF_GO|id=GO:0019733 |text = antibacterial humoral response}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 23643
| Hs_Ensembl = ENSG00000154589
| Hs_RefseqProtein = NP_056179
| Hs_RefseqmRNA = NM_015364
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 8
| Hs_GenLoc_start = 75066141
| Hs_GenLoc_end = 75103859
| Hs_Uniprot = Q9Y6Y9
| Mm_EntrezGene = 17087
| Mm_Ensembl = ENSMUSG00000025779
| Mm_RefseqmRNA = NM_016923
| Mm_RefseqProtein = NP_058619
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 1
| Mm_GenLoc_start = 16673647
| Mm_GenLoc_end = 16694819
| Mm_Uniprot = Q14AM4
}}
}}
'''Lymphocyte antigen 96''', also known as '''LY96''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: LY96 lymphocyte antigen 96| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=23643| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = The MD-2 protein appears to associate with toll-like receptor 4 on the cell surface and confers responsiveness to lipopolysaccyaride (LPS), thus providing a link between the receptor and LPS signaling.<ref name="entrez">{{cite web | title = Entrez Gene: LY96 lymphocyte antigen 96| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=23643| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Shimazu R, Akashi S, Ogata H, ''et al.'' |title=MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. |journal=J. Exp. Med. |volume=189 |issue= 11 |pages= 1777-82 |year= 1999 |pmid= 10359581 |doi= }}
*{{cite journal | author=Kato K, Morrison AM, Nakano T, ''et al.'' |title=ESOP-1, a secreted protein expressed in the hematopoietic, nervous, and reproductive systems of embryonic and adult mice. |journal=Blood |volume=96 |issue= 1 |pages= 362-4 |year= 2000 |pmid= 10891475 |doi= }}
*{{cite journal | author=Dziarski R, Wang Q, Miyake K, ''et al.'' |title=MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. |journal=J. Immunol. |volume=166 |issue= 3 |pages= 1938-44 |year= 2001 |pmid= 11160242 |doi= }}
*{{cite journal | author=Schromm AB, Lien E, Henneke P, ''et al.'' |title=Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. |journal=J. Exp. Med. |volume=194 |issue= 1 |pages= 79-88 |year= 2001 |pmid= 11435474 |doi= }}
*{{cite journal | author=Abreu MT, Vora P, Faure E, ''et al.'' |title=Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. |journal=J. Immunol. |volume=167 |issue= 3 |pages= 1609-16 |year= 2001 |pmid= 11466383 |doi= }}
*{{cite journal | author=Visintin A, Mazzoni A, Spitzer JA, Segal DM |title=Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=98 |issue= 21 |pages= 12156-61 |year= 2001 |pmid= 11593030 |doi= 10.1073/pnas.211445098 }}
*{{cite journal | author=Akashi S, Nagai Y, Ogata H, ''et al.'' |title=Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. |journal=Int. Immunol. |volume=13 |issue= 12 |pages= 1595-9 |year= 2002 |pmid= 11717200 |doi= }}
*{{cite journal | author=Abreu MT, Arnold ET, Thomas LS, ''et al.'' |title=TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. |journal=J. Biol. Chem. |volume=277 |issue= 23 |pages= 20431-7 |year= 2002 |pmid= 11923281 |doi= 10.1074/jbc.M110333200 }}
*{{cite journal | author=Re F, Strominger JL |title=Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness. |journal=J. Biol. Chem. |volume=277 |issue= 26 |pages= 23427-32 |year= 2002 |pmid= 11976338 |doi= 10.1074/jbc.M202554200 }}
*{{cite journal | author=Latz E, Visintin A, Lien E, ''et al.'' |title=Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. |journal=J. Biol. Chem. |volume=277 |issue= 49 |pages= 47834-43 |year= 2003 |pmid= 12324469 |doi= 10.1074/jbc.M207873200 }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal | author=Schröder NW, Morath S, Alexander C, ''et al.'' |title=Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. |journal=J. Biol. Chem. |volume=278 |issue= 18 |pages= 15587-94 |year= 2003 |pmid= 12594207 |doi= 10.1074/jbc.M212829200 }}
*{{cite journal | author=Mullen GE, Kennedy MN, Visintin A, ''et al.'' |title=The role of disulfide bonds in the assembly and function of MD-2. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=100 |issue= 7 |pages= 3919-24 |year= 2003 |pmid= 12642668 |doi= 10.1073/pnas.0630495100 }}
*{{cite journal | author=Ohnishi T, Muroi M, Tanamoto K |title=MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. |journal=Clin. Diagn. Lab. Immunol. |volume=10 |issue= 3 |pages= 405-10 |year= 2004 |pmid= 12738639 |doi= }}
*{{cite journal | author=Thompson PA, Tobias PS, Viriyakosol S, ''et al.'' |title=Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. |journal=J. Biol. Chem. |volume=278 |issue= 31 |pages= 28367-71 |year= 2003 |pmid= 12754215 |doi= 10.1074/jbc.M302921200 }}
*{{cite journal | author=Visintin A, Latz E, Monks BG, ''et al.'' |title=Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. |journal=J. Biol. Chem. |volume=278 |issue= 48 |pages= 48313-20 |year= 2004 |pmid= 12960171 |doi= 10.1074/jbc.M306802200 }}
*{{cite journal | author=Re F, Strominger JL |title=Separate functional domains of human MD-2 mediate Toll-like receptor 4-binding and lipopolysaccharide responsiveness. |journal=J. Immunol. |volume=171 |issue= 10 |pages= 5272-6 |year= 2004 |pmid= 14607928 |doi= }}
*{{cite journal | author=Hamann L, Kumpf O, Müller M, ''et al.'' |title=A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling. |journal=Genes Immun. |volume=5 |issue= 4 |pages= 283-8 |year= 2005 |pmid= 15057266 |doi= 10.1038/sj.gene.6364068 }}
*{{cite journal | author=Gruber A, Mancek M, Wagner H, ''et al.'' |title=Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition. |journal=J. Biol. Chem. |volume=279 |issue= 27 |pages= 28475-82 |year= 2004 |pmid= 15111623 |doi= 10.1074/jbc.M400993200 }}
*{{cite journal | author=Jia HP, Kline JN, Penisten A, ''et al.'' |title=Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. |journal=Am. J. Physiol. Lung Cell Mol. Physiol. |volume=287 |issue= 2 |pages= L428-37 |year= 2004 |pmid= 15121639 |doi= 10.1152/ajplung.00377.2003 }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on MMP10... {November 19, 2007 12:09:43 AM PST}
- SEARCH REDIRECT: Control Box Found: MMP10 {November 19, 2007 12:10:11 AM PST}
- UPDATE PROTEIN BOX: Updating Protein Box, No errors. {November 19, 2007 12:10:12 AM PST}
- UPDATE SUMMARY: Updating Summary, No Errors. {November 19, 2007 12:10:12 AM PST}
- UPDATE CITATIONS: Updating Citations, No Errors. {November 19, 2007 12:10:12 AM PST}
- UPDATED: Updated protein page: MMP10 {November 19, 2007 12:10:19 AM PST}
- INFO: Beginning work on MMP12... {November 19, 2007 12:10:19 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:10:45 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image = PBB_Protein_MMP12_image.jpg
| image_source = [[Protein_Data_Bank|PDB]] rendering based on 1jiz.
| PDB = {{PDB2|1jiz}}, {{PDB2|1jk3}}, {{PDB2|1os2}}, {{PDB2|1os9}}, {{PDB2|1rmz}}, {{PDB2|1ros}}, {{PDB2|1utt}}, {{PDB2|1utz}}, {{PDB2|1y93}}, {{PDB2|1ycm}}, {{PDB2|1z3j}}, {{PDB2|2hu6}}, {{PDB2|2oxu}}, {{PDB2|2oxw}}, {{PDB2|2oxz}}
| Name = Matrix metallopeptidase 12 (macrophage elastase)
| HGNCid = 7158
| Symbol = MMP12
| AltSymbols =; MME; HME; MGC138506
| OMIM = 601046
| ECnumber =
| Homologene = 20547
| MGIid = 97005
| GeneAtlas_image1 = PBB_GE_MMP12_204580_at_tn.png
| Function = {{GNF_GO|id=GO:0004234 |text = macrophage elastase activity}} {{GNF_GO|id=GO:0005509 |text = calcium ion binding}} {{GNF_GO|id=GO:0008270 |text = zinc ion binding}}
| Component = {{GNF_GO|id=GO:0005578 |text = proteinaceous extracellular matrix}}
| Process = {{GNF_GO|id=GO:0000270 |text = peptidoglycan metabolic process}} {{GNF_GO|id=GO:0006508 |text = proteolysis}} {{GNF_GO|id=GO:0006928 |text = cell motility}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 4321
| Hs_Ensembl = ENSG00000110347
| Hs_RefseqProtein = NP_002417
| Hs_RefseqmRNA = NM_002426
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 11
| Hs_GenLoc_start = 102238686
| Hs_GenLoc_end = 102250922
| Hs_Uniprot = P39900
| Mm_EntrezGene = 17381
| Mm_Ensembl = ENSMUSG00000049723
| Mm_RefseqmRNA = NM_008605
| Mm_RefseqProtein = NP_032631
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 9
| Mm_GenLoc_start = 7347406
| Mm_GenLoc_end = 7369499
| Mm_Uniprot = Q3TB28
}}
}}
'''Matrix metallopeptidase 12 (macrophage elastase)''', also known as '''MMP12''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: MMP12 matrix metallopeptidase 12 (macrophage elastase)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4321| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. It is thought that the protein encoded by this gene is cleaved at both ends to yield the active enzyme, but this processing has not been fully described. The enzyme degrades soluble and insoluble elastin. It may play a role in aneurysm formation and studies in mice suggest a role in the development of emphysema. The gene is part of a cluster of MMP genes which localize to chromosome 11q22.3.<ref name="entrez">{{cite web | title = Entrez Gene: MMP12 matrix metallopeptidase 12 (macrophage elastase)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4321| accessdate = }}</ref>
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Nagase H, Woessner JF |title=Matrix metalloproteinases. |journal=J. Biol. Chem. |volume=274 |issue= 31 |pages= 21491-4 |year= 1999 |pmid= 10419448 |doi= }}
*{{cite journal | author=Belaaouaj A, Shipley JM, Kobayashi DK, ''et al.'' |title=Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. |journal=J. Biol. Chem. |volume=270 |issue= 24 |pages= 14568-75 |year= 1995 |pmid= 7782320 |doi= }}
*{{cite journal | author=Shapiro SD, Kobayashi DK, Ley TJ |title=Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. |journal=J. Biol. Chem. |volume=268 |issue= 32 |pages= 23824-9 |year= 1993 |pmid= 8226919 |doi= }}
*{{cite journal | author=Pendás AM, Santamaría I, Alvarez MV, ''et al.'' |title=Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. |journal=Genomics |volume=37 |issue= 2 |pages= 266-8 |year= 1997 |pmid= 8921407 |doi= }}
*{{cite journal | author=Gronski TJ, Martin RL, Kobayashi DK, ''et al.'' |title=Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. |journal=J. Biol. Chem. |volume=272 |issue= 18 |pages= 12189-94 |year= 1997 |pmid= 9115292 |doi= }}
*{{cite journal | author=Edelstein C, Shapiro SD, Klezovitch O, Scanu AM |title=Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology. |journal=J. Biol. Chem. |volume=274 |issue= 15 |pages= 10019-23 |year= 1999 |pmid= 10187779 |doi= }}
*{{cite journal | author=Dias Neto E, Correa RG, Verjovski-Almeida S, ''et al.'' |title=Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=97 |issue= 7 |pages= 3491-6 |year= 2000 |pmid= 10737800 |doi= }}
*{{cite journal | author=Wert SE, Yoshida M, LeVine AM, ''et al.'' |title=Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=97 |issue= 11 |pages= 5972-7 |year= 2000 |pmid= 10801980 |doi= 10.1073/pnas.100448997 }}
*{{cite journal | author=Belaaouaj AA, Li A, Wun TC, ''et al.'' |title=Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. |journal=J. Biol. Chem. |volume=275 |issue= 35 |pages= 27123-8 |year= 2000 |pmid= 10859319 |doi= 10.1074/jbc.M004218200 }}
*{{cite journal | author=Hiller O, Lichte A, Oberpichler A, ''et al.'' |title=Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. |journal=J. Biol. Chem. |volume=275 |issue= 42 |pages= 33008-13 |year= 2000 |pmid= 10930399 |doi= 10.1074/jbc.M001836200 }}
*{{cite journal | author=Terp GE, Christensen IT, Jørgensen FS |title=Structural differences of matrix metalloproteinases. Homology modeling and energy minimization of enzyme-substrate complexes. |journal=J. Biomol. Struct. Dyn. |volume=17 |issue= 6 |pages= 933-46 |year= 2000 |pmid= 10949161 |doi= }}
*{{cite journal | author=Agapova OA, Ricard CS, Salvador-Silva M, Hernandez MR |title=Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. |journal=Glia |volume=33 |issue= 3 |pages= 205-16 |year= 2001 |pmid= 11241738 |doi= }}
*{{cite journal | author=Lang R, Kocourek A, Braun M, ''et al.'' |title=Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. |journal=J. Mol. Biol. |volume=312 |issue= 4 |pages= 731-42 |year= 2001 |pmid= 11575928 |doi= 10.1006/jmbi.2001.4954 }}
*{{cite journal | author=Nar H, Werle K, Bauer MM, ''et al.'' |title=Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor. |journal=J. Mol. Biol. |volume=312 |issue= 4 |pages= 743-51 |year= 2001 |pmid= 11575929 |doi= 10.1006/jmbi.2001.4953 }}
*{{cite journal | author=Joos L, He JQ, Shepherdson MB, ''et al.'' |title=The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. |journal=Hum. Mol. Genet. |volume=11 |issue= 5 |pages= 569-76 |year= 2002 |pmid= 11875051 |doi= }}
*{{cite journal | author=Andolfo A, English WR, Resnati M, ''et al.'' |title=Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor. |journal=Thromb. Haemost. |volume=88 |issue= 2 |pages= 298-306 |year= 2003 |pmid= 12195704 |doi= }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal | author=Vos CM, van Haastert ES, de Groot CJ, ''et al.'' |title=Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. |journal=J. Neuroimmunol. |volume=138 |issue= 1-2 |pages= 106-14 |year= 2003 |pmid= 12742660 |doi= }}
*{{cite journal | author=Anghelina M, Schmeisser A, Krishnan P, ''et al.'' |title=Migration of monocytes/macrophages in vitro and in vivo is accompanied by MMP12-dependent tunnel formation and by neovascularization. |journal=Cold Spring Harb. Symp. Quant. Biol. |volume=67 |issue= |pages= 209-15 |year= 2003 |pmid= 12858542 |doi= }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on MST1R... {November 19, 2007 12:10:45 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:11:10 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Macrophage stimulating 1 receptor (c-met-related tyrosine kinase)
| HGNCid = 7381
| Symbol = MST1R
| AltSymbols =; CDw136; PTK8; RON
| OMIM = 600168
| ECnumber =
| Homologene = 1835
| MGIid = 99614
| GeneAtlas_image1 = PBB_GE_MST1R_205455_at_tn.png
| Function = {{GNF_GO|id=GO:0000166 |text = nucleotide binding}} {{GNF_GO|id=GO:0004713 |text = protein-tyrosine kinase activity}} {{GNF_GO|id=GO:0004872 |text = receptor activity}} {{GNF_GO|id=GO:0005011 |text = macrophage colony stimulating factor receptor activity}} {{GNF_GO|id=GO:0005524 |text = ATP binding}} {{GNF_GO|id=GO:0016740 |text = transferase activity}}
| Component = {{GNF_GO|id=GO:0001725 |text = stress fiber}} {{GNF_GO|id=GO:0005886 |text = plasma membrane}} {{GNF_GO|id=GO:0005887 |text = integral to plasma membrane}}
| Process = {{GNF_GO|id=GO:0006468 |text = protein amino acid phosphorylation}} {{GNF_GO|id=GO:0006928 |text = cell motility}} {{GNF_GO|id=GO:0006952 |text = defense response}} {{GNF_GO|id=GO:0007165 |text = signal transduction}} {{GNF_GO|id=GO:0007275 |text = multicellular organismal development}} {{GNF_GO|id=GO:0007338 |text = single fertilization}} {{GNF_GO|id=GO:0008284 |text = positive regulation of cell proliferation}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 4486
| Hs_Ensembl = ENSG00000164078
| Hs_RefseqProtein = NP_002438
| Hs_RefseqmRNA = NM_002447
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 3
| Hs_GenLoc_start = 49899444
| Hs_GenLoc_end = 49916074
| Hs_Uniprot = Q04912
| Mm_EntrezGene = 19882
| Mm_Ensembl = ENSMUSG00000032584
| Mm_RefseqmRNA = NM_009074
| Mm_RefseqProtein = NP_033100
| Mm_GenLoc_db =
| Mm_GenLoc_chr = 9
| Mm_GenLoc_start = 107764990
| Mm_GenLoc_end = 107778488
| Mm_Uniprot = Q62190
}}
}}
'''Macrophage stimulating 1 receptor (c-met-related tyrosine kinase)''', also known as '''MST1R''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: MST1R macrophage stimulating 1 receptor (c-met-related tyrosine kinase)| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4486| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text =
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Li BQ, Wang MH, Kung HF, ''et al.'' |title=Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor. |journal=Biochem. Biophys. Res. Commun. |volume=216 |issue= 1 |pages= 110-8 |year= 1995 |pmid= 7488076 |doi= 10.1006/bbrc.1995.2598 }}
*{{cite journal | author=Wang MH, Ronsin C, Gesnel MC, ''et al.'' |title=Identification of the ron gene product as the receptor for the human macrophage stimulating protein. |journal=Science |volume=266 |issue= 5182 |pages= 117-9 |year= 1994 |pmid= 7939629 |doi= }}
*{{cite journal | author=Gaudino G, Follenzi A, Naldini L, ''et al.'' |title=RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. |journal=EMBO J. |volume=13 |issue= 15 |pages= 3524-32 |year= 1994 |pmid= 8062829 |doi= }}
*{{cite journal | author=Lee ST, Strunk KM, Spritz RA |title=A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. |journal=Oncogene |volume=8 |issue= 12 |pages= 3403-10 |year= 1993 |pmid= 8247543 |doi= }}
*{{cite journal | author=Ronsin C, Muscatelli F, Mattei MG, Breathnach R |title=A novel putative receptor protein tyrosine kinase of the met family. |journal=Oncogene |volume=8 |issue= 5 |pages= 1195-202 |year= 1993 |pmid= 8386824 |doi= }}
*{{cite journal | author=Collesi C, Santoro MM, Gaudino G, Comoglio PM |title=A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. |journal=Mol. Cell. Biol. |volume=16 |issue= 10 |pages= 5518-26 |year= 1996 |pmid= 8816464 |doi= }}
*{{cite journal | author=Bonaldo MF, Lennon G, Soares MB |title=Normalization and subtraction: two approaches to facilitate gene discovery. |journal=Genome Res. |volume=6 |issue= 9 |pages= 791-806 |year= 1997 |pmid= 8889548 |doi= }}
*{{cite journal | author=Iwama A, Yamaguchi N, Suda T |title=STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. |journal=EMBO J. |volume=15 |issue= 21 |pages= 5866-75 |year= 1997 |pmid= 8918464 |doi= }}
*{{cite journal | author=Sakamoto O, Iwama A, Amitani R, ''et al.'' |title=Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility. |journal=J. Clin. Invest. |volume=99 |issue= 4 |pages= 701-9 |year= 1997 |pmid= 9045873 |doi= }}
*{{cite journal | author=Follenzi A, Bakovic S, Gual P, ''et al.'' |title=Cross-talk between the proto-oncogenes Met and Ron. |journal=Oncogene |volume=19 |issue= 27 |pages= 3041-9 |year= 2000 |pmid= 10871856 |doi= 10.1038/sj.onc.1203620 }}
*{{cite journal | author=Chen YQ, Zhou YQ, Fisher JH, Wang MH |title=Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo. |journal=Oncogene |volume=21 |issue= 41 |pages= 6382-6 |year= 2002 |pmid= 12214279 |doi= 10.1038/sj.onc.1205783 }}
*{{cite journal | author=Chen YQ, Zhou YQ, Fu LH, ''et al.'' |title=Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Recepteur d'origine nantais. |journal=Carcinogenesis |volume=23 |issue= 11 |pages= 1811-9 |year= 2002 |pmid= 12419829 |doi= }}
*{{cite journal | author=Zhou YQ, He C, Chen YQ, ''et al.'' |title=Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. |journal=Oncogene |volume=22 |issue= 2 |pages= 186-97 |year= 2003 |pmid= 12527888 |doi= 10.1038/sj.onc.1206075 }}
*{{cite journal | author=Danilkovitch-Miagkova A, Duh FM, Kuzmin I, ''et al.'' |title=Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=100 |issue= 8 |pages= 4580-5 |year= 2003 |pmid= 12676986 |doi= 10.1073/pnas.0837136100 }}
*{{cite journal | author=Rampino T, Gregorini M, Soccio G, ''et al.'' |title=The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma. |journal=Am. J. Surg. Pathol. |volume=27 |issue= 6 |pages= 779-85 |year= 2003 |pmid= 12766581 |doi= }}
*{{cite journal | author=Penengo L, Rubin C, Yarden Y, Gaudino G |title=c-Cbl is a critical modulator of the Ron tyrosine kinase receptor. |journal=Oncogene |volume=22 |issue= 24 |pages= 3669-79 |year= 2003 |pmid= 12802274 |doi= 10.1038/sj.onc.1206585 }}
*{{cite journal | author=Maggiora P, Lorenzato A, Fracchioli S, ''et al.'' |title=The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness. |journal=Exp. Cell Res. |volume=288 |issue= 2 |pages= 382-9 |year= 2003 |pmid= 12915129 |doi= }}
*{{cite journal | author=Santoro MM, Gaudino G, Marchisio PC |title=The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration. |journal=Dev. Cell |volume=5 |issue= 2 |pages= 257-71 |year= 2003 |pmid= 12919677 |doi= }}
*{{cite journal | author=Angeloni D, Danilkovitch-Miagkova A, Miagkov A, ''et al.'' |title=The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation. |journal=J. Biol. Chem. |volume=279 |issue= 5 |pages= 3726-32 |year= 2004 |pmid= 14597639 |doi= 10.1074/jbc.M309342200 }}
*{{cite journal | author=van den Akker E, van Dijk T, Parren-van Amelsvoort M, ''et al.'' |title=Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors. |journal=Blood |volume=103 |issue= 12 |pages= 4457-65 |year= 2004 |pmid= 14982882 |doi= 10.1182/blood-2003-08-2713 }}
}}
{{refend}}
{{protein-stub}}
- INFO: Beginning work on SLC37A4... {November 19, 2007 12:01:54 AM PST}
- SEARCH REDIRECT: Control Box Found: SLC37A4 {November 19, 2007 12:02:34 AM PST}
- UPDATE PROTEIN BOX: Updating Protein Box, No errors. {November 19, 2007 12:02:36 AM PST}
- UPDATE SUMMARY: Updating Summary, No Errors. {November 19, 2007 12:02:36 AM PST}
- UPDATE CITATIONS: Updating Citations, No Errors. {November 19, 2007 12:02:36 AM PST}
- UPDATED: Updated protein page: SLC37A4 {November 19, 2007 12:02:43 AM PST}
- INFO: Beginning work on SMAD6... {November 19, 2007 12:09:12 AM PST}
- AMBIGUITY: Did not locate an acceptable page to update. {November 19, 2007 12:09:43 AM PST}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = SMAD family member 6
| HGNCid = 6772
| Symbol = SMAD6
| AltSymbols =; HsT17432; MADH6; MADH7
| OMIM = 602931
| ECnumber =
| Homologene = 4079
| MGIid = 1336883
| GeneAtlas_image1 = PBB_GE_SMAD6_207069_s_at_tn.png
| GeneAtlas_image2 = PBB_GE_SMAD6_209886_s_at_tn.png
| Function = {{GNF_GO|id=GO:0004871 |text = signal transducer activity}} {{GNF_GO|id=GO:0005076 |text = receptor signaling protein serine/threonine kinase signaling protein activity}} {{GNF_GO|id=GO:0005515 |text = protein binding}} {{GNF_GO|id=GO:0030617 |text = transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity}}
| Component = {{GNF_GO|id=GO:0005622 |text = intracellular}}
| Process = {{GNF_GO|id=GO:0006350 |text = transcription}} {{GNF_GO|id=GO:0006355 |text = regulation of transcription, DNA-dependent}}
| Orthologs = {{GNF_Ortholog_box
| Hs_EntrezGene = 4091
| Hs_Ensembl = ENSG00000137834
| Hs_RefseqProtein = NP_005576
| Hs_RefseqmRNA = NM_005585
| Hs_GenLoc_db =
| Hs_GenLoc_chr = 15
| Hs_GenLoc_start = 64781722
| Hs_GenLoc_end = 64861377
| Hs_Uniprot = O43541
| Mm_EntrezGene = 17130
| Mm_Ensembl =
| Mm_RefseqmRNA = NM_008542
| Mm_RefseqProtein = NP_032568
| Mm_GenLoc_db =
| Mm_GenLoc_chr =
| Mm_GenLoc_start =
| Mm_GenLoc_end =
| Mm_Uniprot =
}}
}}
'''SMAD family member 6''', also known as '''SMAD6''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: SMAD6 SMAD family member 6| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4091| accessdate = }}</ref>
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot. See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text =
}}
==References==
{{reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal | author=Massagué J |title=TGF-beta signal transduction. |journal=Annu. Rev. Biochem. |volume=67 |issue= |pages= 753-91 |year= 1998 |pmid= 9759503 |doi= 10.1146/annurev.biochem.67.1.753 }}
*{{cite journal | author=Verschueren K, Huylebroeck D |title=Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells. |journal=Cytokine Growth Factor Rev. |volume=10 |issue= 3-4 |pages= 187-99 |year= 2000 |pmid= 10647776 |doi= }}
*{{cite journal | author=Wrana JL, Attisano L |title=The Smad pathway. |journal=Cytokine Growth Factor Rev. |volume=11 |issue= 1-2 |pages= 5-13 |year= 2000 |pmid= 10708948 |doi= }}
*{{cite journal | author=Miyazono K |title=TGF-beta signaling by Smad proteins. |journal=Cytokine Growth Factor Rev. |volume=11 |issue= 1-2 |pages= 15-22 |year= 2000 |pmid= 10708949 |doi= }}
*{{cite journal | author=Riggins GJ, Thiagalingam S, Rozenblum E, ''et al.'' |title=Mad-related genes in the human. |journal=Nat. Genet. |volume=13 |issue= 3 |pages= 347-9 |year= 1996 |pmid= 8673135 |doi= 10.1038/ng0796-347 }}
*{{cite journal | author=Topper JN, Cai J, Qiu Y, ''et al.'' |title=Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=94 |issue= 17 |pages= 9314-9 |year= 1997 |pmid= 9256479 |doi= }}
*{{cite journal | author=Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A |title=Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. |journal=Genes Dev. |volume=12 |issue= 2 |pages= 186-97 |year= 1998 |pmid= 9436979 |doi= }}
*{{cite journal | author=Afrakhte M, Morén A, Jossan S, ''et al.'' |title=Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. |journal=Biochem. Biophys. Res. Commun. |volume=249 |issue= 2 |pages= 505-11 |year= 1998 |pmid= 9712726 |doi= 10.1006/bbrc.1998.9170 }}
*{{cite journal | author=Galvin KM, Donovan MJ, Lynch CA, ''et al.'' |title=A role for smad6 in development and homeostasis of the cardiovascular system. |journal=Nat. Genet. |volume=24 |issue= 2 |pages= 171-4 |year= 2000 |pmid= 10655064 |doi= 10.1038/72835 }}
*{{cite journal | author=Bai S, Shi X, Yang X, Cao X |title=Smad6 as a transcriptional corepressor. |journal=J. Biol. Chem. |volume=275 |issue= 12 |pages= 8267-70 |year= 2000 |pmid= 10722652 |doi= }}
*{{cite journal | author=Kimura N, Matsuo R, Shibuya H, ''et al.'' |title=BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. |journal=J. Biol. Chem. |volume=275 |issue= 23 |pages= 17647-52 |year= 2000 |pmid= 10748100 |doi= 10.1074/jbc.M908622199 }}
*{{cite journal | author=Datta PK, Moses HL |title=STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. |journal=Mol. Cell. Biol. |volume=20 |issue= 9 |pages= 3157-67 |year= 2000 |pmid= 10757800 |doi= }}
*{{cite journal | author=Ebisawa T, Fukuchi M, Murakami G, ''et al.'' |title=Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. |journal=J. Biol. Chem. |volume=276 |issue= 16 |pages= 12477-80 |year= 2001 |pmid= 11278251 |doi= 10.1074/jbc.C100008200 }}
*{{cite journal | author=Itoh F, Asao H, Sugamura K, ''et al.'' |title=Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. |journal=EMBO J. |volume=20 |issue= 15 |pages= 4132-42 |year= 2001 |pmid= 11483516 |doi= 10.1093/emboj/20.15.4132 }}
*{{cite journal | author=Yanagisawa M, Nakashima K, Takeda K, ''et al.'' |title=Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7. |journal=Genes Cells |volume=6 |issue= 12 |pages= 1091-9 |year= 2002 |pmid= 11737269 |doi= }}
*{{cite journal | author=Schiffer M, Schiffer LE, Gupta A, ''et al.'' |title=Inhibitory smads and tgf-Beta signaling in glomerular cells. |journal=J. Am. Soc. Nephrol. |volume=13 |issue= 11 |pages= 2657-66 |year= 2003 |pmid= 12397035 |doi= }}
}}
{{refend}}
{{protein-stub}}
end log.
